data_2kvz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.403 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 HD13 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 34.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.672 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.672 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.623 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 17' ' ' ASN . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 15' ' ' ASP . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.756 HG13 HD12 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.734 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.756 HD12 HG13 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.734 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 . . . . . 0 CA--C 1.514 -0.435 0 CA-C-O 120.635 0.255 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.605 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.605 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 21' ' ' ILE . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.608 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' ASN . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' GLU . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.516 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.703 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.434 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.516 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' HG22 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.416 ' HB2' HD11 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.703 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.401 HG22 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG12 HG22 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.632 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.442 HG23 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.412 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.603 ' SD ' HD21 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 9' ' ' VAL . 29.8 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.418 ' HB3' HD11 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' C ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.45 HG21 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.456 HG22 HG21 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mttm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.611 ' ND2' HD22 ' A' ' 14' ' ' LEU . 57.5 t30 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 ' ND2' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.501 ' HG3' ' HH ' ' A' ' 69' ' ' TYR . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.815 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm . . . . . 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.015 0.436 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.688 0.28 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.515 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.682 0.753 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HB3' HD21 ' A' ' 14' ' ' LEU . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.613 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.448 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HZ1' ' HB2' ' A' ' 40' ' ' LYS . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 42' ' ' ILE . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.529 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.402 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.598 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 59' ' ' THR . 65.8 t30 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.571 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m120 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.711 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.934 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.044 0.449 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.603 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.727 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.6 p-10 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.629 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.535 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.803 ' HB2' ' HZ3' ' A' ' 72' ' ' LYS . 9.3 mtmp? . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.9 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.685 ' HG3' HE21 ' A' ' 70' ' ' GLN . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HE1' HD11 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' HH ' ' A' ' 50' ' ' TYR . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.496 HD11 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.685 HE21 ' HG3' ' A' ' 16' ' ' GLU . 86.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 12' ' ' ASN . 7.9 m120 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD2' ' HH ' ' A' ' 69' ' ' TYR . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' HH ' ' HD2' ' A' ' 13' ' ' TYR . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 58' ' ' PHE . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.555 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.521 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.551 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.441 ' HE2' ' CE2' ' A' ' 50' ' ' TYR . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.441 ' CE2' ' HE2' ' A' ' 39' ' ' MET . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.741 0.305 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -138.91 13.32 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.373 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.74 141.97 32.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.19 22.71 75.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.333 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -122.12 97.84 45.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.312 . . . . 0.0 110.682 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.47 148.03 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 112.076 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.91 18.32 17.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.403 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 HD13 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 34.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp -82.43 7.42 14.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.05 127.16 56.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.653 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.97 165.54 3.78 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.031 2.487 . . . . 0.0 112.984 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.15 45.0 0.81 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.878 0.847 . . . . 0.0 110.508 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -102.57 -50.59 3.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.449 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.05 37.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.42 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.1 tp -102.39 124.74 48.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.038 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.67 126.98 55.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.987 0.422 . . . . 0.0 111.441 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -103.48 105.62 15.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.324 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -90.34 109.56 20.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -91.03 122.66 33.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -144.22 164.61 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -78.61 32.41 0.2 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.3 t60 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.841 -0.599 . . . . 0.0 109.795 -176.39 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.49 -28.46 28.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.83 116.57 30.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.97 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.47 161.5 30.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.459 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -97.63 115.21 65.73 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 39.8 Cg_endo -89.96 107.67 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.955 2.437 . . . . 0.0 112.944 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.82 86.22 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.672 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.672 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.47 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.623 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt -68.35 -32.33 72.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.634 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . . . -67.92 165.68 29.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.956 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' ALA . 13.9 Cg_endo -56.69 170.07 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.986 2.457 . . . . 0.0 113.158 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -56.06 -48.77 75.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.745 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -98.03 -174.65 2.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.219 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -13.96 60.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.608 0.718 . . . . 0.0 109.643 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.1 mt -117.71 140.02 50.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.889 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 81' ' ' HIS . 1.0 OUTLIER -70.52 143.17 51.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.2 -34.27 71.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.03 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.421 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 70.2 m80 -81.18 101.44 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -79.21 99.93 7.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -62.82 100.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.124 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 173.01 -23.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.244 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.8 m80 . . . . . 0 C--O 1.246 0.871 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.664 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.68 89.84 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.885 0.741 . . . . 0.0 111.465 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -159.38 -61.11 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.172 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.02 157.67 53.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.918 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -110.58 94.26 18.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 95.4 Cg_endo -89.17 140.49 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.874 2.383 . . . . 0.0 112.165 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 -78.39 76.6 4.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 17' ' ' ASN . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 15' ' ' ASP . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.756 HG13 HD12 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.602 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.734 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD11 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.756 HD12 HG13 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.734 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -77.9 -7.11 56.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.4 140.23 36.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.497 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.46 115.53 2.51 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.489 2.126 . . . . 0.0 112.679 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.93 150.47 49.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.03 177.03 9.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.857 0.36 . . . . 0.0 110.667 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.64 90.19 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.62 140.72 53.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -34.56 72.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.457 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -89.75 88.81 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -64.34 -48.09 76.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -102.14 114.6 28.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -61.63 122.89 16.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 111.73 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -99.57 132.56 44.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.701 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.198 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 61.98 79.34 0.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.73 0.644 . . . . 0.0 110.944 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -150.46 136.8 18.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.052 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.06 -115.91 4.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.152 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -173.1 174.21 1.21 Allowed Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 23.6 Cg_exo -65.51 99.51 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.727 1.618 . . . . 0.0 110.112 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 -80.73 149.34 29.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 6' ' ' PRO . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.605 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.605 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG23 HG22 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.404 ' HB2' HD12 ' A' ' 21' ' ' ILE . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? -78.26 6.3 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.25 138.48 13.64 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.205 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.37 -9.15 25.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.999 2.466 . . . . 0.0 112.31 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.1 100.09 6.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.04 119.15 29.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.59 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.13 162.24 14.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.195 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.87 -5.67 47.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.282 -173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.27 -26.33 60.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.557 0.694 . . . . 0.0 109.46 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -110.01 -43.51 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.369 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -111.27 115.67 29.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -94.01 168.64 10.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.986 0.422 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.63 -30.78 5.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.551 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.67 164.17 21.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.154 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.053 -177.01 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 121.262 0.554 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.18 128.4 34.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.094 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -94.32 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.68 -93.26 0.9 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.653 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -128.74 158.95 70.61 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.76 -13.79 28.38 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.976 2.451 . . . . 0.0 113.642 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -85.54 14.25 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.608 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' ASN . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' GLU . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.516 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.703 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.434 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.516 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' HG22 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.416 ' HB2' HD11 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.703 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp -64.31 -40.25 95.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.53 77.46 0.41 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 109.694 -170.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.34 21.04 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.986 2.457 . . . . 0.0 113.707 -170.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -161.61 124.02 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -77.38 165.78 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.271 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.42 3.14 25.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.266 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.22 -21.01 46.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.496 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 18.7 mm-40 -81.24 131.05 35.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 12.5 m-70 74.35 121.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.158 0.911 . . . . 0.0 111.175 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.09 122.54 29.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.741 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -119.33 159.23 24.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -75.7 -23.57 56.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.088 0.47 . . . . 0.0 110.289 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -112.96 133.49 54.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.817 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 m80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.319 173.642 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.674 0.273 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -92.14 -45.69 8.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.201 0.524 . . . . 0.0 109.725 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 167.18 18.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.684 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.88 35.15 89.14 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -98.26 133.83 22.56 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.37 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.19 111.83 1.54 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.452 2.101 . . . . 0.0 111.28 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -76.83 134.13 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.401 HG22 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG12 HG22 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.632 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.49 HG22 HG12 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.442 HG23 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.412 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.8 -22.05 61.62 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.57 112.66 28.25 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.117 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.54 153.34 70.05 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.761 2.308 . . . . 0.0 112.441 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . 10.4 tp10 -57.51 -23.34 49.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.189 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -55.39 -37.46 67.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.559 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.81 -25.01 13.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.965 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 52.4 tp -68.5 -36.97 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.327 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' OE2' ' HA ' ' A' ' 82' ' ' HIS . 28.9 tt0 -70.68 108.13 4.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -62.92 -46.42 87.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.119 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -109.96 97.25 6.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 1.4 t60 -72.05 122.8 21.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.141 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -59.78 -48.67 80.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.419 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -90.72 91.3 8.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 71.4 t60 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.066 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -127.09 121.35 31.25 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -158.15 167.55 29.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.298 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.15 34.48 26.42 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 44.7 mtpt -130.7 129.82 22.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.79 0.328 . . . . 0.0 110.921 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 66.8 Cg_endo -90.87 106.84 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.937 2.425 . . . . 0.0 111.92 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.02 175.64 7.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.603 ' SD ' HD21 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.603 HD21 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 9' ' ' VAL . 29.8 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp -68.24 143.07 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . . . -97.0 172.83 4.59 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.184 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.633 ' HD2' ' HB2' ' A' ' 73' ' ' ALA . 5.4 Cg_endo -50.15 -39.98 51.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.158 1.906 . . . . 0.0 111.032 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 49.4 mt-10 49.5 79.04 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.212 0.945 . . . . 0.0 111.586 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.3 -1.11 56.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.888 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.58 167.35 16.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.743 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -101.1 6.66 43.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -80.15 -32.31 38.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 175.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.3 147.44 22.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 167.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -109.3 96.84 6.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.68 0.752 . . . . 0.0 110.592 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -93.3 118.05 30.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.355 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -117.94 138.82 51.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.983 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -73.56 172.35 11.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.64 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.622 -0.704 . . . . 0.0 109.599 175.132 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.078 0.466 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.6 143.83 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -69.81 -42.46 73.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.4 5.81 57.81 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 10.2 mptt -128.75 123.38 22.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.55 -21.33 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.344 2.029 . . . . 0.0 113.089 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 57.13 29.0 15.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.418 ' HB3' HD11 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.484 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -82.14 54.41 2.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . -141.25 -51.52 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.462 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 15.1 Cg_exo -70.35 109.65 2.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.977 1.785 . . . . 0.0 110.629 168.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -76.77 127.17 32.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -76.98 124.79 28.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.981 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.39 -30.59 62.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 111.378 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.88 95.73 9.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.279 0.561 . . . . 0.0 110.994 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' A' ' 81' ' ' HIS . 5.5 tm-20 -62.21 129.07 39.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.273 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 32.6 m170 -60.26 -17.83 44.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.826 0.346 . . . . 0.0 111.652 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 4.2 m-70 78.85 75.64 0.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.284 1.034 . . . . 0.0 111.862 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -95.52 -5.14 43.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.437 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -134.96 142.6 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.597 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -95.95 -46.07 6.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.01 176.389 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.414 0.15 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.23 152.35 29.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.602 0.239 . . . . 0.0 110.807 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.72 -33.44 25.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.21 -120.31 3.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.173 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 60' ' ' GLU . 29.2 mttp -130.8 131.15 23.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 5.7 Cg_exo -79.05 121.66 5.01 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.007 2.471 . . . . 0.0 112.157 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -76.24 74.28 3.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' C ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.45 HG21 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.456 HG22 HG21 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -68.38 -14.61 63.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . 67.15 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.84 0.713 . . . . 0.0 111.151 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 16.8 Cg_exo -66.56 101.71 0.56 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.775 2.317 . . . . 0.0 112.484 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -100.74 151.03 22.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.52 -35.73 81.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.965 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.31 -176.76 0.2 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 123.993 0.808 . . . . 0.0 110.916 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.18 93.09 4.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.59 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 37.7 tt0 -64.86 138.55 58.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -74.58 -3.73 32.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.59 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 38.5 m80 -116.54 134.12 55.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.22 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.0 -33.3 65.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -121.32 118.52 29.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.085 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 77.6 t60 -54.85 -36.36 64.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.835 -169.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 35.3 t-80 . . . . . 0 C--O 1.246 0.905 0 O-C-N 123.433 0.458 . . . . 0.0 110.022 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -122.37 -179.73 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.754 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.53 155.52 21.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.386 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.07 -99.26 1.96 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.292 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -127.7 154.88 77.87 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.53 -30.37 61.36 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.912 2.408 . . . . 0.0 112.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -93.5 15.18 16.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.611 ' ND2' HD22 ' A' ' 14' ' ' LEU . 57.5 t30 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.611 HD22 ' ND2' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.501 ' HG3' ' HH ' ' A' ' 69' ' ' TYR . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.815 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -52.21 -41.97 63.14 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . . . 62.65 -179.77 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 O-C-N 123.786 0.679 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 33.4 Cg_exo -61.23 99.21 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.506 1.471 . . . . 0.0 111.558 172.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -65.22 123.3 19.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 63.78 69.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.884 0.74 . . . . 0.0 109.906 -170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 174.86 8.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.996 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.63 19.97 1.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.121 0.486 . . . . 0.0 110.948 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -119.91 134.74 55.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.56 101.22 9.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -74.48 129.01 36.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.257 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -82.75 -10.06 59.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.917 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -135.26 115.03 12.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.412 0.625 . . . . 0.0 111.992 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -122.13 -25.75 4.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.596 174.867 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -93.32 129.5 39.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.559 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 139.12 52.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.83 -171.43 46.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.196 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -106.56 114.86 61.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.948 0.374 . . . . 0.0 110.23 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.58 106.25 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.254 1.97 . . . . 0.0 110.755 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -70.64 116.81 11.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.457 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HG3' ' HA ' ' A' ' 74' ' ' PRO . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -54.49 -40.72 68.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 94.15 3.73 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 57.2 Cg_endo -68.66 157.85 60.15 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.947 2.431 . . . . 0.0 113.689 -169.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 47.8 mt-10 -111.27 -167.04 1.13 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.39 174.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 63.89 13.31 7.47 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.08 -165.81 1.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.765 -171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.12 -57.19 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.323 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.28 77.36 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.528 0.68 . . . . 0.0 111.754 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -162.44 -40.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -93.2 160.82 14.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.375 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.34 153.46 47.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -68.1 -34.41 76.35 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.025 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -82.72 -14.3 54.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.063 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.633 -177.19 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -93.28 145.15 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.93 -10.83 56.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.786 0.327 . . . . 0.0 110.99 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.81 54.1 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.182 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 55.9 mttp -122.64 107.59 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 16.7 Cg_exo -67.84 -39.52 11.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.989 2.459 . . . . 0.0 112.063 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -80.68 57.98 3.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.459 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.515 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.483 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -71.23 -33.32 69.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.72 96.4 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.924 0.765 . . . . 0.0 111.993 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.94 -28.77 28.86 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.778 2.319 . . . . 0.0 111.547 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -71.92 120.15 17.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.359 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -83.57 -68.51 0.71 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.218 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.81 -79.8 0.24 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.87 148.02 33.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.913 0.387 . . . . 0.0 111.229 -173.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.44 109.69 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -78.87 92.77 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.096 0.474 . . . . 0.0 109.737 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.31 132.55 47.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -71.17 -12.77 61.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.643 0.259 . . . . 0.0 111.63 -170.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -84.05 -3.39 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.498 0.666 . . . . 0.0 109.392 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.48 167.77 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.335 -177.767 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.832 0.349 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -104.76 108.52 20.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.748 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -100.78 100.77 11.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.41 151.2 49.44 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.04 111.73 49.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 117.175 0.487 . . . . 0.0 111.255 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 4.9 Cg_exo -80.9 -21.93 6.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -82.51 75.35 9.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HB3' HD21 ' A' ' 14' ' ' LEU . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.57 ' HB ' HG23 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.613 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -68.96 139.07 55.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.98 145.01 45.57 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.396 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.613 ' HB3' HD21 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.63 125.9 20.66 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.392 2.061 . . . . 0.0 111.397 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.25 168.57 8.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.75 -11.17 53.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.1 0.476 . . . . 0.0 110.815 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 -8.12 58.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 74' ' ' PRO . 48.6 tp -114.87 124.6 52.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.045 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -107.21 163.57 12.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.304 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -74.84 -40.69 60.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.804 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -132.92 146.3 51.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -113.88 163.78 14.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.579 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -82.86 -19.54 37.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.96 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -97.97 -8.58 27.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.386 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -67.4 -42.09 83.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -129.43 154.6 46.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.353 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.59 -25.85 66.75 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.633 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -134.12 96.05 16.25 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.356 0.598 . . . . 0.0 110.379 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HB2' ' HG3' ' A' ' 8' ' ' GLN . 83.1 Cg_endo -88.08 -2.22 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.875 2.383 . . . . 0.0 113.744 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 56.98 42.53 26.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 6' ' ' PRO . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.514 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.448 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HZ1' ' HB2' ' A' ' 40' ' ' LYS . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 42' ' ' ILE . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.529 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.402 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.598 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.529 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt -74.24 90.69 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 112.81 32.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.674 0.273 . . . . 0.0 111.61 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 81.3 Cg_endo -80.48 -18.71 9.38 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.592 2.195 . . . . 0.0 111.388 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -89.18 88.8 7.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.886 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -99.13 150.28 22.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.067 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.66 -16.65 63.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.9 tp -67.7 -62.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.537 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -94.52 108.98 20.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.918 0.39 . . . . 0.0 110.054 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.43 131.85 43.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.812 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -111.61 122.33 47.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 110.817 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -68.23 -33.91 75.26 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -95.62 61.23 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -66.17 132.49 48.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.076 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.345 179.569 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.773 0.32 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -93.44 -15.32 25.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.819 0.342 . . . . 0.0 110.848 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -93.43 11.67 27.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.6 36.74 3.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.157 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 7' ' ' ASN . 63.0 mttp -65.76 -42.08 51.84 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 17.3 Cg_exo -69.98 46.71 0.54 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.258 1.972 . . . . 0.0 112.33 173.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 5' ' ' LYS . 65.8 t30 -172.47 54.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.571 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m120 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.446 ' HB3' HD12 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.711 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.934 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp -87.69 134.42 33.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . -82.77 -50.79 0.73 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.451 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 73' ' ' ALA . 39.4 Cg_endo -66.7 163.44 33.07 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.778 1.652 . . . . 0.0 111.844 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.89 -70.75 0.19 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.83 28.02 13.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.257 0.551 . . . . 0.0 110.289 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.95 32.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.709 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.66 10.75 10.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.947 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.08 95.38 0.72 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.265 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -75.83 132.29 40.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -71.14 77.3 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -169.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -140.66 -51.51 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -120.09 174.08 6.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.309 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 55.89 48.35 18.19 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.6 0.563 . . . . 0.0 109.987 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.443 -173.247 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.668 0.271 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -60.46 2.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.296 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -92.57 25.57 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.895 0.378 . . . . 0.0 111.329 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.11 -37.96 87.7 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt 66.91 95.53 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 C-N-CA 123.596 0.758 . . . . 0.0 110.883 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.2 177.49 7.75 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.112 2.541 . . . . 0.0 113.261 -172.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 61.06 76.09 0.38 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.919 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.603 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG23 HD13 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.556 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG21 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.727 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -69.6 -2.57 11.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 50.04 79.5 0.34 Allowed Pre-proline 0 N--CA 1.463 0.192 0 O-C-N 123.748 0.655 . . . . 0.0 111.212 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.89 94.41 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.729 2.286 . . . . 0.0 112.367 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.24 139.63 46.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.52 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.03 -10.82 59.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.373 0.606 . . . . 0.0 110.322 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.42 -23.46 63.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.203 173.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.78 158.97 17.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.764 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.56 -179.32 3.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.642 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 63.65 35.21 11.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.937 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -74.08 -33.52 63.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -115.99 111.1 19.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.244 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -64.79 -37.26 87.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.09 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -107.0 95.08 5.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.561 178.157 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.56 120.72 26.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -78.95 56.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.02 167.25 50.98 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.27 121.86 48.71 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.955 0.378 . . . . 0.0 110.919 -178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.35 100.48 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.42 2.08 . . . . 0.0 111.224 173.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -73.05 108.85 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.6 p-10 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.629 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG21 HG21 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.535 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.803 ' HB2' ' HZ3' ' A' ' 72' ' ' LYS . 9.3 mtmp? -69.76 143.01 53.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . . . -68.93 166.62 26.08 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.681 172.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 73' ' ' ALA . 86.5 Cg_exo -45.04 106.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.802 2.335 . . . . 0.0 112.82 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.39 -19.69 62.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.195 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -79.02 -15.8 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.36 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.26 -15.15 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.648 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.7 114.46 25.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.815 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.64 139.44 58.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.501 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -75.4 -34.06 61.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.576 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -86.27 113.71 22.5 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 166.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.21 -24.5 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.1 t60 68.48 11.59 8.41 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.273 0.358 . . . . 0.0 111.373 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -114.83 134.76 54.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.165 0.507 . . . . 0.0 110.948 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.057 174.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.95 0.405 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -165.96 160.53 16.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.376 -175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.3 101.1 5.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.57 178.44 32.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.604 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.602 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 9.8 mtmp? -127.04 168.13 15.62 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 86.0 Cg_exo -48.2 111.78 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.675 2.25 . . . . 0.0 112.77 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 -77.76 114.33 16.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.33 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.9 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.685 ' HG3' HE21 ' A' ' 70' ' ' GLN . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HE1' HD11 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD13 ' HH ' ' A' ' 50' ' ' TYR . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.496 HD11 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.465 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.685 HE21 ' HG3' ' A' ' 16' ' ' GLU . 86.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt -70.68 -27.09 63.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.26 94.89 37.57 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.42 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -92.3 145.73 2.81 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.949 2.433 . . . . 0.0 111.655 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.65 163.56 21.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.106 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -81.83 -10.32 59.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.0 109.853 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.29 14.18 4.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.946 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.6 tp -160.94 168.36 24.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -131.9 155.96 46.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.902 0.382 . . . . 0.0 110.611 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -79.88 -21.39 44.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.97 -39.67 75.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.446 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -134.41 110.82 9.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.783 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 85' ' ' HIS . 2.0 m80 -79.83 -168.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -73.61 -8.4 55.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.496 0.665 . . . . 0.0 109.225 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 83' ' ' HIS . 92.0 m-70 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.947 -1.025 . . . . 0.0 108.329 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.196 0.522 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.77 159.96 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.093 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -86.09 -12.38 50.22 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.38 -154.11 19.74 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.762 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.09 134.98 24.98 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.04 78.19 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.76 2.307 . . . . 0.0 112.043 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -79.4 70.01 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 12' ' ' ASN . 7.9 m120 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD2' ' HH ' ' A' ' 69' ' ' TYR . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' HH ' ' HD2' ' A' ' 13' ' ' TYR . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp -72.17 142.5 49.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.34 96.09 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 123.659 0.599 . . . . 0.0 110.926 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.92 155.54 67.35 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.988 2.458 . . . . 0.0 112.847 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.92 147.46 50.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.298 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.55 -54.77 5.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.567 ' HB2' ' HE1' ' A' ' 80' ' ' HIS . . . -85.33 132.28 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 30.5 tp -78.9 172.15 14.19 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -64.44 115.3 4.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.933 0.397 . . . . 0.0 110.587 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.567 ' HE1' ' HB2' ' A' ' 77' ' ' ALA . 29.2 m80 -102.84 109.64 21.28 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -65.54 -30.57 71.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.163 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -90.97 22.06 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.112 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -136.3 -53.27 0.73 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -95.73 91.35 6.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.838 -178.127 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -100.04 72.24 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.911 0.386 . . . . 0.0 110.079 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -161.88 6.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.369 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.21 6.94 25.08 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.19 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -118.4 100.93 51.43 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.826 0.345 . . . . 0.0 110.117 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.28 106.33 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.997 2.465 . . . . 0.0 111.822 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 -78.49 127.61 32.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.428 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.521 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 58' ' ' PHE . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.555 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.521 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.551 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.441 ' HE2' ' CE2' ' A' ' 50' ' ' TYR . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.441 ' CE2' ' HE2' ' A' ' 39' ' ' MET . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt -76.53 74.6 3.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 135.22 96.27 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.173 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.71 116.83 2.82 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.841 2.36 . . . . 0.0 112.181 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.74 -38.74 73.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.977 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -75.37 102.41 5.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.73 -172.77 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.1 8.77 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 0.0 110.8 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.05 164.45 30.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -72.99 -15.59 61.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.044 0.449 . . . . 0.0 110.942 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -136.94 167.84 20.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.725 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -101.53 136.31 41.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -74.77 83.54 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.1 t60 171.21 -37.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 114.552 -1.203 . . . . 0.0 109.648 175.564 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.458 HD21 ' N ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' SER . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.546 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.428 HD11 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 23.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' SER . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 42' ' ' ILE . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HB3' HG22 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.666 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.635 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 16' ' ' GLU . 3.9 m-20 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.764 HG11 HD13 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.459 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 . . . . . 0 CA--C 1.514 -0.435 0 CA-C-O 120.635 0.255 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 42' ' ' ILE . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HG21 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.604 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.638 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.522 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.446 ' HB2' HD12 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG21 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 24' ' ' SER . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 70' ' ' GLN . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG13 HG22 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 HG11 ' A' ' 37' ' ' VAL . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 9' ' ' VAL . 34.2 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.535 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.535 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 52.7 mttm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.523 HD21 ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HD21 ' A' ' 14' ' ' LEU . 2.0 t-20 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' OD1' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.843 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 14' ' ' LEU . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm . . . . . 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.015 0.436 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.457 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.457 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 14' ' ' LEU . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.688 0.28 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.453 HD12 HD12 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.682 0.753 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 15' ' ' ASP . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.62 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG21 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.6 ' HB ' HG21 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 38' ' ' PRO . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 43' ' ' LYS . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 42' ' ' ILE . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 71' ' ' LYS . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HG3' ' HE1' ' A' ' 45' ' ' TYR . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.535 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' THR . 65.8 t30 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 83.3 m-20 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.96 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.798 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.96 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.044 0.449 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.496 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.556 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.3 p30 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 58' ' ' PHE . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 11' ' ' VAL . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.474 ' NZ ' ' HB2' ' A' ' 72' ' ' LYS . 9.3 mtmp? . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 89.0 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 48' ' ' LEU . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HE1' HD12 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 48' ' ' LEU . 23.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD13 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB2' HG13 ' A' ' 9' ' ' VAL . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.741 0.305 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -138.91 13.32 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.373 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.74 141.97 32.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.19 22.71 75.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.333 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -122.12 97.84 45.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.312 . . . . 0.0 110.682 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.47 148.03 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 112.076 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.91 18.32 17.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' SER . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.546 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.428 HD11 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 23.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp -82.43 7.42 14.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.05 127.16 56.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.653 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.97 165.54 3.78 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.031 2.487 . . . . 0.0 112.984 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.15 45.0 0.81 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.878 0.847 . . . . 0.0 110.508 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -102.57 -50.59 3.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.449 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.05 37.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.42 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.1 tp -102.39 124.74 48.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.038 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.67 126.98 55.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.987 0.422 . . . . 0.0 111.441 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -103.48 105.62 15.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.324 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -90.34 109.56 20.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -91.03 122.66 33.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -144.22 164.61 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 21.5 p-80 -78.61 32.41 0.2 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 16.3 t60 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.841 -0.599 . . . . 0.0 109.795 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.49 -28.46 28.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.83 116.57 30.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.97 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.47 161.5 30.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.459 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -97.63 115.21 65.73 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 39.8 Cg_endo -89.96 107.67 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.955 2.437 . . . . 0.0 112.944 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.82 86.22 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' SER . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 42' ' ' ILE . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HB3' HG22 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.666 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.635 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt -68.35 -32.33 72.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -67.92 165.68 29.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.956 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 13.9 Cg_endo -56.69 170.07 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.986 2.457 . . . . 0.0 113.158 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -56.06 -48.77 75.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.745 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -98.03 -174.65 2.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.219 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -13.96 60.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.608 0.718 . . . . 0.0 109.643 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.1 mt -117.71 140.02 50.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.889 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 81' ' ' HIS . 1.0 OUTLIER -70.52 143.17 51.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.2 -34.27 71.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.03 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 70.2 m80 -81.18 101.44 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -79.21 99.93 7.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 31.8 p-80 -62.82 100.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.124 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 13.7 t-80 173.01 -23.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.244 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.8 m80 . . . . . 0 C--O 1.246 0.871 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.664 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.68 89.84 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.885 0.741 . . . . 0.0 111.465 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -159.38 -61.11 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.172 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.02 157.67 53.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.918 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -110.58 94.26 18.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 95.4 Cg_endo -89.17 140.49 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.874 2.383 . . . . 0.0 112.165 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 -78.39 76.6 4.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 16' ' ' GLU . 3.9 m-20 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.764 HG11 HD13 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.459 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -77.9 -7.11 56.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -85.4 140.23 36.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.497 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 51.6 Cg_exo -55.46 115.53 2.51 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.489 2.126 . . . . 0.0 112.679 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.93 150.47 49.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.03 177.03 9.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.857 0.36 . . . . 0.0 110.667 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.64 90.19 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.62 140.72 53.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -34.56 72.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.457 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -89.75 88.81 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -64.34 -48.09 76.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -102.14 114.6 28.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -61.63 122.89 16.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 111.73 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -99.57 132.56 44.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.701 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.198 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 61.98 79.34 0.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.73 0.644 . . . . 0.0 110.944 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -150.46 136.8 18.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.052 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.06 -115.91 4.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.152 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -173.1 174.21 1.21 Allowed Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 23.6 Cg_exo -65.51 99.51 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.727 1.618 . . . . 0.0 110.112 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 -80.73 149.34 29.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' PRO . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 42' ' ' ILE . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HG21 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.604 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? -78.26 6.3 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -146.25 138.48 13.64 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.205 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 17.2 Cg_exo -68.37 -9.15 25.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.999 2.466 . . . . 0.0 112.31 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.1 100.09 6.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.04 119.15 29.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.59 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.13 162.24 14.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.195 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 81' ' ' HIS . 80.6 mt -75.87 -5.67 47.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.282 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.27 -26.33 60.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.557 0.694 . . . . 0.0 109.46 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -110.01 -43.51 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.369 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 64.2 t60 -111.27 115.67 29.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -94.01 168.64 10.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.986 0.422 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.63 -30.78 5.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.551 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.67 164.17 21.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.154 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.053 -177.01 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 121.262 0.554 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.18 128.4 34.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.094 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -94.32 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.68 -93.26 0.9 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.653 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -128.74 158.95 70.61 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.76 -13.79 28.38 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.976 2.451 . . . . 0.0 113.642 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -85.54 14.25 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.638 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.522 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.446 ' HB2' HD12 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp -64.31 -40.25 95.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.53 77.46 0.41 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 109.694 -170.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.34 21.04 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.986 2.457 . . . . 0.0 113.707 -170.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -161.61 124.02 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -77.38 165.78 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.271 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.42 3.14 25.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.266 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.22 -21.01 46.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.496 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 18.7 mm-40 -81.24 131.05 35.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 12.5 m-70 74.35 121.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.158 0.911 . . . . 0.0 111.175 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.09 122.54 29.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.741 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -119.33 159.23 24.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -75.7 -23.57 56.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.088 0.47 . . . . 0.0 110.289 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -112.96 133.49 54.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.817 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 m80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.319 173.642 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.674 0.273 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -92.14 -45.69 8.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.201 0.524 . . . . 0.0 109.725 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 167.18 18.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.684 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.88 35.15 89.14 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 58.6 tttp -98.26 133.83 22.56 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.37 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 25.6 Cg_exo -63.19 111.83 1.54 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.452 2.101 . . . . 0.0 111.28 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -76.83 134.13 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG21 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 24' ' ' SER . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 70' ' ' GLN . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG13 HG22 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.8 -22.05 61.62 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.57 112.66 28.25 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.117 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.54 153.34 70.05 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.761 2.308 . . . . 0.0 112.441 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . 10.4 tp10 -57.51 -23.34 49.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.189 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -55.39 -37.46 67.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.559 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.81 -25.01 13.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.965 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 52.4 tp -68.5 -36.97 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.327 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.606 ' OE2' ' HA ' ' A' ' 82' ' ' HIS . 28.9 tt0 -70.68 108.13 4.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -62.92 -46.42 87.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.119 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -109.96 97.25 6.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 1.4 t60 -72.05 122.8 21.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.141 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -59.78 -48.67 80.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.419 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -90.72 91.3 8.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.635 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 71.4 t60 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.066 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -127.09 121.35 31.25 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -158.15 167.55 29.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.298 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.15 34.48 26.42 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 44.7 mtpt -130.7 129.82 22.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.79 0.328 . . . . 0.0 110.921 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 66.8 Cg_endo -90.87 106.84 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.937 2.425 . . . . 0.0 111.92 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.02 175.64 7.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 HG11 ' A' ' 37' ' ' VAL . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 9' ' ' VAL . 34.2 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp -68.24 143.07 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -97.0 172.83 4.59 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.184 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 5.4 Cg_endo -50.15 -39.98 51.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.158 1.906 . . . . 0.0 111.032 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 49.4 mt-10 49.5 79.04 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.212 0.945 . . . . 0.0 111.586 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.3 -1.11 56.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.888 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.58 167.35 16.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.743 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -101.1 6.66 43.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -80.15 -32.31 38.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 175.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.3 147.44 22.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 167.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -109.3 96.84 6.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.68 0.752 . . . . 0.0 110.592 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -93.3 118.05 30.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.355 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -117.94 138.82 51.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.983 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -73.56 172.35 11.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.64 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.622 -0.704 . . . . 0.0 109.599 175.132 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.078 0.466 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.6 143.83 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -69.81 -42.46 73.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.4 5.81 57.81 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 10.2 mptt -128.75 123.38 22.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.55 -21.33 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.344 2.029 . . . . 0.0 113.089 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 57.13 29.0 15.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -82.14 54.41 2.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . -141.25 -51.52 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.462 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 15.1 Cg_exo -70.35 109.65 2.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.977 1.785 . . . . 0.0 110.629 168.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -76.77 127.17 32.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -76.98 124.79 28.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.981 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.39 -30.59 62.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 111.378 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.88 95.73 9.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.279 0.561 . . . . 0.0 110.994 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 81' ' ' HIS . 5.5 tm-20 -62.21 129.07 39.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.273 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 32.6 m170 -60.26 -17.83 44.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.826 0.346 . . . . 0.0 111.652 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.479 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 4.2 m-70 78.85 75.64 0.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.284 1.034 . . . . 0.0 111.862 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -95.52 -5.14 43.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.437 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -134.96 142.6 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.597 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -95.95 -46.07 6.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.01 176.389 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.414 0.15 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.23 152.35 29.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.602 0.239 . . . . 0.0 110.807 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.72 -33.44 25.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.21 -120.31 3.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.173 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.626 ' HD2' ' HB2' ' A' ' 60' ' ' GLU . 29.2 mttp -130.8 131.15 23.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 5.7 Cg_exo -79.05 121.66 5.01 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.007 2.471 . . . . 0.0 112.157 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -76.24 74.28 3.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.535 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.535 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 52.7 mttm -68.38 -14.61 63.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . 67.15 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.84 0.713 . . . . 0.0 111.151 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 16.8 Cg_exo -66.56 101.71 0.56 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.775 2.317 . . . . 0.0 112.484 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -100.74 151.03 22.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.52 -35.73 81.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.965 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.31 -176.76 0.2 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 123.993 0.808 . . . . 0.0 110.916 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.18 93.09 4.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.684 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 37.7 tt0 -64.86 138.55 58.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -74.58 -3.73 32.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.684 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 38.5 m80 -116.54 134.12 55.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.22 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.0 -33.3 65.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -121.32 118.52 29.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.085 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 77.6 t60 -54.85 -36.36 64.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.835 -169.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 35.3 t-80 . . . . . 0 C--O 1.246 0.905 0 O-C-N 123.433 0.458 . . . . 0.0 110.022 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -122.37 -179.73 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.754 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.53 155.52 21.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.386 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.07 -99.26 1.96 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.292 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -127.7 154.88 77.87 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.53 -30.37 61.36 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.912 2.408 . . . . 0.0 112.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -93.5 15.18 16.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HD21 ' A' ' 14' ' ' LEU . 2.0 t-20 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD21 ' OD1' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.843 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 14' ' ' LEU . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -52.21 -41.97 63.14 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . 62.65 -179.77 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 O-C-N 123.786 0.679 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 33.4 Cg_exo -61.23 99.21 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.506 1.471 . . . . 0.0 111.558 172.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -65.22 123.3 19.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 63.78 69.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.884 0.74 . . . . 0.0 109.906 -170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 174.86 8.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.996 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.63 19.97 1.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.121 0.486 . . . . 0.0 110.948 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -119.91 134.74 55.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.56 101.22 9.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -74.48 129.01 36.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.257 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -82.75 -10.06 59.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.917 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -135.26 115.03 12.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.412 0.625 . . . . 0.0 111.992 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -122.13 -25.75 4.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.596 174.867 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -93.32 129.5 39.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.559 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 139.12 52.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.83 -171.43 46.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.196 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -106.56 114.86 61.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.948 0.374 . . . . 0.0 110.23 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.58 106.25 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.254 1.97 . . . . 0.0 110.755 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -70.64 116.81 11.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.457 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.457 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 14' ' ' LEU . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 74' ' ' PRO . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -54.49 -40.72 68.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 94.15 3.73 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 57.2 Cg_endo -68.66 157.85 60.15 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.947 2.431 . . . . 0.0 113.689 -169.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 47.8 mt-10 -111.27 -167.04 1.13 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.39 174.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 63.89 13.31 7.47 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.08 -165.81 1.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.765 -171.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.12 -57.19 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.323 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.28 77.36 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.528 0.68 . . . . 0.0 111.754 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -162.44 -40.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -93.2 160.82 14.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.375 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.34 153.46 47.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -68.1 -34.41 76.35 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.025 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -82.72 -14.3 54.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.063 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.633 -177.19 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -93.28 145.15 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.93 -10.83 56.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.786 0.327 . . . . 0.0 110.99 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.81 54.1 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.182 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 55.9 mttp -122.64 107.59 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 16.7 Cg_exo -67.84 -39.52 11.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.989 2.459 . . . . 0.0 112.063 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -80.68 57.98 3.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.459 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.453 HD12 HD12 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -71.23 -33.32 69.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.72 96.4 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.924 0.765 . . . . 0.0 111.993 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.94 -28.77 28.86 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.778 2.319 . . . . 0.0 111.547 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -71.92 120.15 17.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.359 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -83.57 -68.51 0.71 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.218 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.81 -79.8 0.24 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.87 148.02 33.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.913 0.387 . . . . 0.0 111.229 -173.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.44 109.69 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -78.87 92.77 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.096 0.474 . . . . 0.0 109.737 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.31 132.55 47.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -71.17 -12.77 61.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.643 0.259 . . . . 0.0 111.63 -170.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -84.05 -3.39 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.498 0.666 . . . . 0.0 109.392 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.48 167.77 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.335 -177.767 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 72.6 mtm . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.832 0.349 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -104.76 108.52 20.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.748 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 1' ' ' MET . 99.1 m-85 -100.78 100.77 11.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.41 151.2 49.44 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.04 111.73 49.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 117.175 0.487 . . . . 0.0 111.255 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 4.9 Cg_exo -80.9 -21.93 6.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -82.51 75.35 9.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 15' ' ' ASP . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.62 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG21 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.6 ' HB ' HG21 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -68.96 139.07 55.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.98 145.01 45.57 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.396 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HB3' HD23 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.63 125.9 20.66 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.392 2.061 . . . . 0.0 111.397 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.25 168.57 8.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.75 -11.17 53.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.1 0.476 . . . . 0.0 110.815 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 -8.12 58.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 74' ' ' PRO . 48.6 tp -114.87 124.6 52.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.045 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -107.21 163.57 12.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.304 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -74.84 -40.69 60.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.804 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -132.92 146.3 51.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -113.88 163.78 14.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.579 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -82.86 -19.54 37.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.96 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -97.97 -8.58 27.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.386 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -67.4 -42.09 83.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -129.43 154.6 46.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.353 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.59 -25.85 66.75 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.633 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -134.12 96.05 16.25 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.356 0.598 . . . . 0.0 110.379 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HB2' ' HG3' ' A' ' 8' ' ' GLN . 83.1 Cg_endo -88.08 -2.22 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.875 2.383 . . . . 0.0 113.744 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 56.98 42.53 26.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 6' ' ' PRO . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 38' ' ' PRO . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 43' ' ' LYS . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 42' ' ' ILE . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 71' ' ' LYS . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HG3' ' HE1' ' A' ' 45' ' ' TYR . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.535 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt -74.24 90.69 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 112.81 32.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.674 0.273 . . . . 0.0 111.61 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 81.3 Cg_endo -80.48 -18.71 9.38 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.592 2.195 . . . . 0.0 111.388 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -89.18 88.8 7.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.886 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -99.13 150.28 22.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.067 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.66 -16.65 63.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.9 tp -67.7 -62.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.537 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -94.52 108.98 20.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.918 0.39 . . . . 0.0 110.054 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.43 131.85 43.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.812 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -111.61 122.33 47.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 110.817 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -68.23 -33.91 75.26 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -95.62 61.23 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -66.17 132.49 48.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.076 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.345 179.569 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.773 0.32 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -93.44 -15.32 25.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.819 0.342 . . . . 0.0 110.848 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -93.43 11.67 27.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.6 36.74 3.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.157 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 63.0 mttp -65.76 -42.08 51.84 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 17.3 Cg_exo -69.98 46.71 0.54 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.258 1.972 . . . . 0.0 112.33 173.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' THR . 65.8 t30 -172.47 54.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 83.3 m-20 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.96 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.96 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp -87.69 134.42 33.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . -82.77 -50.79 0.73 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.451 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 73' ' ' ALA . 39.4 Cg_endo -66.7 163.44 33.07 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.778 1.652 . . . . 0.0 111.844 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.89 -70.75 0.19 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.83 28.02 13.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.257 0.551 . . . . 0.0 110.289 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.95 32.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.709 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.66 10.75 10.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.947 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.08 95.38 0.72 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.265 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -75.83 132.29 40.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -71.14 77.3 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -169.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -140.66 -51.51 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -120.09 174.08 6.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.309 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 55.89 48.35 18.19 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.6 0.563 . . . . 0.0 109.987 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.443 -173.247 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.668 0.271 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -60.46 2.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.296 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -92.57 25.57 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.895 0.378 . . . . 0.0 111.329 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.11 -37.96 87.7 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt 66.91 95.53 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 C-N-CA 123.596 0.758 . . . . 0.0 110.883 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.2 177.49 7.75 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.112 2.541 . . . . 0.0 113.261 -172.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 61.06 76.09 0.38 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.919 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.496 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.556 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 73' ' ' ALA . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -69.6 -2.57 11.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' H ' ' HG2' ' A' ' 71' ' ' LYS . . . 50.04 79.5 0.34 Allowed Pre-proline 0 N--CA 1.463 0.192 0 O-C-N 123.748 0.655 . . . . 0.0 111.212 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.89 94.41 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.729 2.286 . . . . 0.0 112.367 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.24 139.63 46.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.52 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.03 -10.82 59.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.373 0.606 . . . . 0.0 110.322 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.42 -23.46 63.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.203 173.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.78 158.97 17.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.764 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.56 -179.32 3.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.642 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 63.65 35.21 11.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.937 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -74.08 -33.52 63.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -115.99 111.1 19.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.244 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -64.79 -37.26 87.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.09 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -107.0 95.08 5.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.561 178.157 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.56 120.72 26.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -78.95 56.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.02 167.25 50.98 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.27 121.86 48.71 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.955 0.378 . . . . 0.0 110.919 -178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.35 100.48 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.42 2.08 . . . . 0.0 111.224 173.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -73.05 108.85 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.3 p30 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 58' ' ' PHE . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 11' ' ' VAL . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.474 ' NZ ' ' HB2' ' A' ' 72' ' ' LYS . 9.3 mtmp? -69.76 143.01 53.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -68.93 166.62 26.08 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.681 172.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 86.5 Cg_exo -45.04 106.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.802 2.335 . . . . 0.0 112.82 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.39 -19.69 62.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.195 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -79.02 -15.8 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.36 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.26 -15.15 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.648 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.7 114.46 25.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.815 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.64 139.44 58.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.501 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -75.4 -34.06 61.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.576 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -86.27 113.71 22.5 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 166.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.21 -24.5 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.1 t60 68.48 11.59 8.41 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.273 0.358 . . . . 0.0 111.373 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -114.83 134.76 54.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.165 0.507 . . . . 0.0 110.948 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.057 174.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.95 0.405 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -165.96 160.53 16.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.376 -175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.3 101.1 5.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.57 178.44 32.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.604 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -127.04 168.13 15.62 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 86.0 Cg_exo -48.2 111.78 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.675 2.25 . . . . 0.0 112.77 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 -77.76 114.33 16.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.33 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 89.0 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 48' ' ' LEU . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HE1' HD12 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.452 ' NE2' HD13 ' A' ' 48' ' ' LEU . 23.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt -70.68 -27.09 63.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.26 94.89 37.57 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.42 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -92.3 145.73 2.81 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.949 2.433 . . . . 0.0 111.655 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.65 163.56 21.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.106 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -81.83 -10.32 59.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.0 109.853 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.29 14.18 4.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.946 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.6 tp -160.94 168.36 24.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -131.9 155.96 46.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.902 0.382 . . . . 0.0 110.611 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -79.88 -21.39 44.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.97 -39.67 75.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.446 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -134.41 110.82 9.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.783 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HB2' ' H ' ' A' ' 85' ' ' HIS . 2.0 m80 -79.83 -168.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -73.61 -8.4 55.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.496 0.665 . . . . 0.0 109.225 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.524 ' H ' ' HB2' ' A' ' 83' ' ' HIS . 92.0 m-70 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.947 -1.025 . . . . 0.0 108.329 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.196 0.522 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.77 159.96 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.093 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -86.09 -12.38 50.22 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.38 -154.11 19.74 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.762 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 37.4 mtmm -122.09 134.98 24.98 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 7.3 Cg_exo -73.04 78.19 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.76 2.307 . . . . 0.0 112.043 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -79.4 70.01 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD13 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB2' HG13 ' A' ' 9' ' ' VAL . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp -72.17 142.5 49.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.34 96.09 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 123.659 0.599 . . . . 0.0 110.926 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.92 155.54 67.35 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.988 2.458 . . . . 0.0 112.847 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.92 147.46 50.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.298 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.55 -54.77 5.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.33 132.28 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 30.5 tp -78.9 172.15 14.19 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -64.44 115.3 4.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.933 0.397 . . . . 0.0 110.587 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -102.84 109.64 21.28 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -65.54 -30.57 71.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.163 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -90.97 22.06 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.112 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -136.3 -53.27 0.73 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -95.73 91.35 6.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.838 -178.127 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -100.04 72.24 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.911 0.386 . . . . 0.0 110.079 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -161.88 6.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.369 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.21 6.94 25.08 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.19 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -118.4 100.93 51.43 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.826 0.345 . . . . 0.0 110.117 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.28 106.33 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.997 2.465 . . . . 0.0 111.822 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 -78.49 127.61 32.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.428 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt -76.53 74.6 3.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 135.22 96.27 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.173 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.71 116.83 2.82 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.841 2.36 . . . . 0.0 112.181 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.74 -38.74 73.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.977 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -75.37 102.41 5.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.73 -172.77 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.1 8.77 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 0.0 110.8 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.05 164.45 30.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -72.99 -15.59 61.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.044 0.449 . . . . 0.0 110.942 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -136.94 167.84 20.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.725 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -101.53 136.31 41.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -74.77 83.54 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.1 t60 171.21 -37.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 114.552 -1.203 . . . . 0.0 109.648 175.564 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' SER . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.546 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.428 HD11 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 34.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' SER . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 42' ' ' ILE . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HB3' HG22 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.666 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.635 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.764 HG11 HD13 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.459 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 . . . . . 0 CA--C 1.514 -0.435 0 CA-C-O 120.635 0.255 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 42' ' ' ILE . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HG21 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.604 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.638 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.522 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.446 ' HB2' HD12 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG21 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 24' ' ' SER . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 70' ' ' GLN . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG13 HG22 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.41 HD22 ' CB ' ' A' ' 24' ' ' SER . 14.3 m120 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.41 ' CB ' HD22 ' A' ' 12' ' ' ASN . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 HG11 ' A' ' 37' ' ' VAL . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 9' ' ' VAL . 29.8 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.475 HD22 ' C ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.535 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.535 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 52.7 mttm . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.591 ' ND2' HD21 ' A' ' 14' ' ' LEU . 57.5 t30 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.591 HD21 ' ND2' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.843 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 14' ' ' LEU . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm . . . . . 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.015 0.436 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.457 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.457 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 14' ' ' LEU . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.688 0.28 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.453 HD12 HD12 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.682 0.753 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 15' ' ' ASP . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.62 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG21 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.6 ' HB ' HG21 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 38' ' ' PRO . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 43' ' ' LYS . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 42' ' ' ILE . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 71' ' ' LYS . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HG3' ' HE1' ' A' ' 45' ' ' TYR . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.535 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' THR . 65.8 t30 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 13.0 m120 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.96 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.798 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.96 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 121.044 0.449 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.496 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.556 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 120.946 0.403 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.6 p-10 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 58' ' ' PHE . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 11' ' ' VAL . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.474 ' NZ ' ' HB2' ' A' ' 72' ' ' LYS . 9.3 mtmp? . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.9 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.727 ' HG3' HE21 ' A' ' 70' ' ' GLN . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 48' ' ' LEU . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HE1' HD12 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.727 HE21 ' HG3' ' A' ' 16' ' ' GLU . 86.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ASN . 7.9 m120 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD13 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB2' HG13 ' A' ' 9' ' ' VAL . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.741 0.305 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -138.91 13.32 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 110.373 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -100.74 141.97 32.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.19 22.71 75.8 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.333 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -122.12 97.84 45.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.754 0.312 . . . . 0.0 110.682 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.47 148.03 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.212 2.608 . . . . 0.0 112.076 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -98.91 18.32 17.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.123 0.487 . . . . 0.0 109.998 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -81.45 148.22 29.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.507 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.3 t -100.52 128.25 52.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.975 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 m -89.34 102.69 15.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.092 0.472 . . . . 0.0 110.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 68.0 t -92.63 119.83 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.14 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.43 125.78 53.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.504 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' SER . 96.5 m-85 -92.7 91.64 7.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.692 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB2' HG12 ' A' ' 68' ' ' ILE . 89.2 mt -86.05 143.61 28.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.43 -173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' HG23 ' A' ' 21' ' ' ILE . 8.2 t70 -82.88 -74.41 0.36 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.396 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -165.19 -44.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.881 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -83.53 27.67 0.6 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.614 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 62.96 22.39 13.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.244 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -104.59 132.11 51.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.129 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 9.0 t -81.93 117.95 22.57 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 15' ' ' ASP . 15.8 pt -83.99 -2.52 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 140.3 33.94 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.434 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.99 130.34 23.41 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.704 2.27 . . . . 0.0 111.879 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 m -49.76 124.14 9.2 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.64 0.588 . . . . 0.0 111.2 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 60.6 tp -89.25 119.57 29.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.47 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -88.41 95.25 10.13 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.837 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 67.4 tp -72.93 108.93 6.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.601 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.2 t -116.69 107.03 14.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.259 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.71 -143.04 6.66 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 69.1 mt -88.67 158.82 18.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -76.46 134.27 39.59 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.1 t30 67.36 21.97 9.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.639 0.733 . . . . 0.0 110.239 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 35.7 tt0 -90.76 136.31 33.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.22 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.31 111.42 15.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 170.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.546 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 48.1 p90 -102.89 175.42 5.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.508 0.67 . . . . 0.0 112.519 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -112.51 153.08 28.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.207 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.9 m -90.71 118.93 69.01 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.86 0.362 . . . . 0.0 111.287 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 10.0 Cg_exo -71.96 119.43 6.18 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.801 2.334 . . . . 0.0 111.814 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -122.49 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.161 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.46 134.83 40.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.994 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -86.36 91.94 8.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.271 0.558 . . . . 0.0 109.74 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.2 mt -82.49 120.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.992 -175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.05 26.03 9.58 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.67 0.606 . . . . 0.0 112.3 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 66.11 52.1 39.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.41 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -98.07 153.96 18.06 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.627 -0.337 . . . . 0.0 110.418 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -95.57 136.09 36.41 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.85 106.54 0.59 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 61.6 tp -64.15 -51.7 62.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.653 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 55.3 tttm 173.26 151.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.462 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -126.33 167.65 15.21 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 168.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.86 153.44 30.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.103 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 m -63.85 -27.04 68.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.972 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.88 86.99 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.214 0.53 . . . . 0.0 110.954 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 55' ' ' LEU . 40.2 pt -135.22 -38.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.441 174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 54' ' ' ILE . 85.0 mt -83.1 114.39 21.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.42 -132.54 1.74 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 32' ' ' ASN . 28.0 m -135.48 154.65 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 72.2 m-85 -59.07 112.28 1.63 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -81.85 178.85 8.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.439 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -88.11 5.57 40.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.37 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -139.75 142.7 32.17 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.499 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.76 112.66 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.91 2.406 . . . . 0.0 112.634 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.35 147.34 26.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.5 m -118.9 116.85 27.35 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 122.316 -0.24 . . . . 0.0 111.178 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.428 HD11 ' OH ' ' A' ' 35' ' ' TYR . 64.8 mt -107.54 127.24 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 0.0 110.428 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -100.42 104.5 15.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.163 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.1 mt -105.98 111.62 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 14' ' ' LEU . 35.2 mt -105.55 129.6 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.312 -172.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.5 115.5 28.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.255 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 34.2 tt0 -91.35 141.96 28.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -62.68 118.91 8.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.538 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 21.6 pttp -82.43 7.42 14.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.133 0.492 . . . . 0.0 110.741 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.05 127.16 56.67 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.653 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.97 165.54 3.78 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.031 2.487 . . . . 0.0 112.984 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.15 45.0 0.81 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.878 0.847 . . . . 0.0 110.508 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -102.57 -50.59 3.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.449 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.05 37.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.42 175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 67.1 tp -102.39 124.74 48.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.038 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.67 126.98 55.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.987 0.422 . . . . 0.0 111.441 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -103.48 105.62 15.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.324 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -90.34 109.56 20.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.453 . . . . 0.0 110.384 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -91.03 122.66 33.87 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.835 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -144.22 164.61 30.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.576 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.413 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 21.5 p-80 -78.61 32.41 0.2 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 16.3 t60 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.841 -0.599 . . . . 0.0 109.795 -176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -83.49 -28.46 28.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.83 116.57 30.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.97 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.47 161.5 30.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.459 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -97.63 115.21 65.73 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 39.8 Cg_endo -89.96 107.67 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.955 2.437 . . . . 0.0 112.944 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.82 86.22 5.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.383 0.611 . . . . 0.0 109.561 176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -132.71 101.32 5.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.285 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.2 t -88.05 118.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.119 0.485 . . . . 0.0 110.202 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -92.74 102.86 15.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.69 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 66.8 t -88.57 108.58 18.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.036 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -101.5 125.38 48.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' SER . 94.5 m-85 -94.11 92.21 7.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.07 154.4 18.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.648 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 16' ' ' GLU . 18.5 t70 -87.87 -165.68 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.171 168.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 43.4 tt0 -83.0 -27.37 30.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.106 0.479 . . . . 0.0 109.823 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -81.63 5.29 18.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 68.14 28.05 6.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.421 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 93.5 m -97.73 130.32 44.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 3.4 t -65.95 112.24 3.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.243 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 42' ' ' ILE . 20.5 pt -83.36 -19.44 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 110.665 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.25 158.6 60.46 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.285 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.32 138.69 87.24 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.32 2.013 . . . . 0.0 112.014 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -67.11 133.48 49.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.425 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 55.3 tp -97.16 116.46 29.41 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.872 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.47 101.29 13.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.262 0.553 . . . . 0.0 110.161 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 50.1 tp -89.75 111.71 22.78 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.42 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 p -125.02 131.44 53.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.455 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.65 -145.52 4.14 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.142 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.42 152.3 19.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.706 0.288 . . . . 0.0 110.543 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.77 134.66 51.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.248 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.4 t30 65.07 23.12 12.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.457 0.646 . . . . 0.0 110.932 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.4 130.43 39.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.256 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 115.42 6.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 54.5 p90 -95.52 163.76 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.243 -173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -121.95 146.67 46.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.27 116.18 42.13 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.912 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.68 109.67 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.589 2.193 . . . . 0.0 111.132 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -80.77 92.02 6.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.837 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -79.39 143.11 35.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -113.24 112.4 23.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 45.2 mm -71.75 140.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -53.88 104.73 0.11 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.187 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' HA2' ' HE2' ' A' ' 72' ' ' LYS . . . 90.78 8.74 65.02 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.738 176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 74.7 m-85 -117.75 139.84 50.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.244 0.545 . . . . 0.0 111.085 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -112.78 160.27 18.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.848 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -69.99 119.14 13.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.865 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.83 -53.66 14.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 77.1 tttt 179.59 164.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.061 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE1' HG12 ' A' ' 67' ' ' ILE . 9.7 m-85 -95.62 121.15 37.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.947 0.403 . . . . 0.0 110.954 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 19.8 t70 -83.97 -22.71 31.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.578 0.704 . . . . 0.0 109.385 175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 m -120.1 148.67 43.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.482 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -83.78 124.04 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.702 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 pt -83.47 -19.18 9.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.8 tp -81.33 105.27 12.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.861 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 168.71 -160.12 33.48 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.058 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.72 166.06 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.412 0.149 . . . . 0.0 110.828 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 69.5 m-85 -62.35 127.93 33.67 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.674 175.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 p -91.83 178.82 5.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.757 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.63 -33.92 35.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.448 0.642 . . . . 0.0 110.17 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.2 m -99.65 148.52 34.86 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.028 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.7 109.04 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.189 2.593 . . . . 0.0 112.11 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' HB3' HG22 ' A' ' 9' ' ' VAL . 34.7 tt0 -86.23 148.35 25.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.625 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -118.27 127.52 53.8 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.63 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 11' ' ' VAL . 66.0 mt -107.19 106.67 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 91.7 m-20 -89.1 101.64 14.3 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.666 HG12 ' HE1' ' A' ' 50' ' ' TYR . 59.9 mt -98.85 105.38 17.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.253 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.8 mt -100.7 132.41 46.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.86 0.362 . . . . 0.0 110.867 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 82.3 m-85 -101.66 157.49 16.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.285 0.564 . . . . 0.0 111.535 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -129.36 136.31 49.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.179 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HE2' ' HB3' ' A' ' 73' ' ' ALA . 83.5 tttt -75.49 135.67 40.65 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.635 ' HE2' ' HA2' ' A' ' 44' ' ' GLY . 48.6 mtmt -68.35 -32.33 72.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -67.92 165.68 29.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.956 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 13.9 Cg_endo -56.69 170.07 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.986 2.457 . . . . 0.0 113.158 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -56.06 -48.77 75.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.745 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -98.03 -174.65 2.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.219 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.91 -13.96 60.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.608 0.718 . . . . 0.0 109.643 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.1 mt -117.71 140.02 50.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.889 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 81' ' ' HIS . 1.0 OUTLIER -70.52 143.17 51.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -59.2 -34.27 71.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.03 -173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 79' ' ' GLU . 70.2 m80 -81.18 101.44 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -79.21 99.93 7.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 6.7 p80 -62.82 100.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.124 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 13.7 t-80 173.01 -23.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.244 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.8 m80 . . . . . 0 C--O 1.246 0.871 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.664 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 59.68 89.84 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.885 0.741 . . . . 0.0 111.465 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -159.38 -61.11 0.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.172 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.02 157.67 53.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.918 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -110.58 94.26 18.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.776 0.322 . . . . 0.0 110.866 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 95.4 Cg_endo -89.17 140.49 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.874 2.383 . . . . 0.0 112.165 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 63.8 t30 -78.39 76.6 4.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.397 0.617 . . . . 0.0 109.762 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 99.2 mt-30 -138.53 134.69 34.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.163 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 96.0 t -93.07 130.32 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.9 m -98.06 100.71 12.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.797 0.332 . . . . 0.0 110.623 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.4 t -88.48 121.24 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.957 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.51 126.25 53.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -97.7 98.38 9.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.67 157.32 17.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 112.165 -171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -106.93 18.96 21.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.068 0.937 . . . . 0.0 109.154 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER 76.54 -34.64 0.23 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.65 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.18 20.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.521 0.329 . . . . 0.0 111.507 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 70.27 -3.73 1.75 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.77 0.828 . . . . 0.0 111.787 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -83.03 135.47 34.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.023 0.44 . . . . 0.0 110.017 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -100.98 109.55 21.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 pt -70.11 -19.9 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.192 0.52 . . . . 0.0 110.961 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.49 151.94 76.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.457 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.9 154.18 52.07 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.524 2.15 . . . . 0.0 112.213 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 p -62.54 116.39 5.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 59.7 tp -89.65 115.2 26.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -85.96 102.89 14.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 1.2 tt -84.61 110.52 18.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -95.84 141.78 28.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.889 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.9 -158.86 10.33 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 81.5 mt -102.4 154.72 18.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.29 132.09 52.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.471 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.28 16.98 10.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.233 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -83.43 134.25 34.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.775 0.321 . . . . 0.0 110.705 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.53 125.17 28.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.241 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -131.38 160.28 35.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.764 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -104.56 136.49 44.0 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.764 HG11 HD13 ' A' ' 54' ' ' ILE . 9.5 p -85.03 130.39 52.43 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 120.743 0.306 . . . . 0.0 110.431 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 9.5 Cg_exo -70.79 100.34 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.294 1.996 . . . . 0.0 111.962 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtt -86.35 77.33 9.51 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -74.96 116.89 16.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.999 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -90.22 91.85 8.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.219 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.0 mt -82.84 129.35 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.521 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HG3' HG22 ' A' ' 42' ' ' ILE . 57.8 mttp 58.9 20.05 7.7 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.344 0.657 . . . . 0.0 111.935 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 10.87 81.81 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.203 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -50.01 123.95 9.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.099 0.45 . . . . 0.0 110.67 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.1 m -88.39 128.25 35.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.311 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 68' ' ' ILE . 66.9 tp -59.03 117.03 4.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.704 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 51.0 tp -76.9 -49.89 14.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 58.3 tttp 166.63 143.1 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.986 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 53' ' ' GLU . 19.9 p90 -93.76 113.93 26.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.94 -45.45 85.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.263 0.554 . . . . 0.0 110.467 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.1 t -85.66 108.43 18.01 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 42.2 mt-10 -67.19 152.17 46.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.209 0.528 . . . . 0.0 110.992 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 37' ' ' VAL . 43.0 mt -94.02 123.71 46.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.47 -168.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.08 123.5 44.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -80.35 54.79 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.956 -176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.61 121.21 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.549 0.34 . . . . 0.0 110.59 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 97.4 m-85 -70.92 137.02 48.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.411 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.2 p -134.37 175.07 9.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.664 0.268 . . . . 0.0 110.849 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.77 -23.67 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.105 0.478 . . . . 0.0 110.82 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -95.63 125.66 48.43 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.21 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 51.5 Cg_exo -54.74 112.16 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.568 2.179 . . . . 0.0 111.632 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.91 111.21 20.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.734 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 m -79.78 103.75 9.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.314 0.578 . . . . 0.0 110.87 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.459 HG23 HG12 ' A' ' 54' ' ' ILE . 46.4 mm -93.21 95.38 5.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.706 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -81.81 88.21 6.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.679 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.5 mt -84.91 101.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 47' ' ' LEU . 70.3 mt -94.3 116.7 36.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.449 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 95.7 m-85 -99.14 165.62 11.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.234 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -130.36 142.67 50.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -66.73 145.56 55.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -77.9 -7.11 56.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.344 0.592 . . . . 0.0 109.953 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -85.4 140.23 36.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.497 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 51.6 Cg_exo -55.46 115.53 2.51 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.489 2.126 . . . . 0.0 112.679 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.93 150.47 49.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -81.03 177.03 9.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.857 0.36 . . . . 0.0 110.667 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.64 90.19 8.18 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.62 140.72 53.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -34.56 72.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.457 174.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -89.75 88.81 7.51 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -64.34 -48.09 76.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.39 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -102.14 114.6 28.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -61.63 122.89 16.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 111.73 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -99.57 132.56 44.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.701 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.198 179.333 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 61.98 79.34 0.26 Allowed 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.73 0.644 . . . . 0.0 110.944 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -150.46 136.8 18.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.052 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.06 -115.91 4.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.152 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -173.1 174.21 1.21 Allowed Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 23.6 Cg_exo -65.51 99.51 0.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 121.727 1.618 . . . . 0.0 110.112 166.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 41.3 m-80 -80.73 149.34 29.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 45.0 tt0 -118.45 117.68 29.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.34 0.59 . . . . 0.0 111.772 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -101.51 109.71 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.136 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 64' ' ' THR . 18.5 m -89.35 112.73 23.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.275 0.56 . . . . 0.0 110.674 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 57.7 t -92.02 112.02 25.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.177 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -103.0 113.39 26.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.728 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 90.5 m-85 -82.32 100.55 10.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.446 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.93 -177.96 3.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.535 0.683 . . . . 0.0 112.047 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 17.6 t70 -128.39 177.86 6.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.618 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -63.59 -33.95 76.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.581 0.705 . . . . 0.0 109.135 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -85.43 4.59 34.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.203 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 62.93 17.34 9.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.079 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -83.29 132.89 35.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -64.89 105.57 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.073 0.464 . . . . 0.0 110.453 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 69' ' ' TYR . 17.8 pt -81.37 -17.44 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.65 142.23 40.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.278 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.73 138.48 76.33 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.747 2.298 . . . . 0.0 111.834 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 p -58.75 128.06 35.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.225 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 57.8 tp -89.2 120.53 30.66 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.738 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -91.69 93.03 8.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.294 0.569 . . . . 0.0 110.383 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.56 75.44 10.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.571 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 1.7 p -99.28 137.54 37.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.609 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' PRO . . . -170.99 -130.81 1.26 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.455 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.8 mt -75.25 -165.13 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.736 0.779 . . . . 0.0 112.516 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -131.9 141.08 49.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.351 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.33 13.77 9.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.889 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.97 144.64 30.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.062 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.95 117.84 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.9 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.6 p90 -95.31 174.48 7.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.166 0.508 . . . . 0.0 111.297 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -140.77 138.79 34.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 7.1 p -114.68 132.03 23.11 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-O 120.934 0.397 . . . . 0.0 111.465 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 16.0 Cg_exo -69.05 135.73 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.597 2.198 . . . . 0.0 110.915 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.3 mtt -85.67 -41.46 15.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.9 mttt 64.56 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.941 0.776 . . . . 0.0 111.695 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -117.2 112.63 21.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 110.048 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 6.7 mt -88.69 166.73 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.483 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 42' ' ' ILE . 60.4 mttp -49.71 102.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . . . 68.45 38.24 86.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.355 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.616 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 60.7 m-85 -111.34 139.62 46.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.248 0.547 . . . . 0.0 111.125 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 62.5 m -112.33 144.86 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.641 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.4 tp -76.4 115.32 16.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.914 0.387 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.86 -46.63 20.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 176.76 133.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.583 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -91.53 102.78 15.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 167.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 66' ' ' ASN . 28.6 t70 -62.38 -46.79 87.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.505 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.2 m -90.68 133.76 34.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.01 141.36 58.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.054 0.454 . . . . 0.0 110.945 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.504 HG22 HG21 ' A' ' 65' ' ' ILE . 41.5 pt -91.19 7.22 4.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.886 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.32 108.09 17.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.373 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.87 -170.54 38.07 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.807 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.65 156.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.525 0.202 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 56.1 m-85 -60.58 110.48 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.327 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -103.79 159.57 15.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.604 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 1.4 mp0 -61.23 -38.74 87.74 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.044 0.45 . . . . 0.0 110.278 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.5 m -64.28 132.76 95.43 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.645 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 39.1 Cg_exo -60.97 114.55 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.336 176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -96.55 149.6 21.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.407 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 10' ' ' THR . 96.3 m -129.53 109.08 10.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.339 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 54' ' ' ILE . 52.5 mt -89.81 94.66 4.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 51' ' ' ASP . 10.6 p-10 -84.65 95.13 8.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.737 0.779 . . . . 0.0 110.764 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.9 116.06 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.297 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.8 mt -98.97 121.18 49.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.947 0.403 . . . . 0.0 111.458 -172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 72.5 m-85 -111.91 160.88 16.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.492 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.08 159.02 44.09 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -73.6 150.4 41.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 8.4 mtmp? -78.26 6.3 8.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -146.25 138.48 13.64 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.205 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 17.2 Cg_exo -68.37 -9.15 25.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.999 2.466 . . . . 0.0 112.31 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.1 100.09 6.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -89.04 119.15 29.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.59 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.13 162.24 14.72 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.195 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 81' ' ' HIS . 80.6 mt -75.87 -5.67 47.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.282 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.27 -26.33 60.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.557 0.694 . . . . 0.0 109.46 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -110.01 -43.51 3.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.369 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 64.2 t60 -111.27 115.67 29.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.242 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -94.01 168.64 10.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.986 0.422 . . . . 0.0 110.855 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -118.63 -30.78 5.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.551 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.67 164.17 21.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.154 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.053 -177.01 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 121.262 0.554 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.18 128.4 34.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.094 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -94.32 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.68 -93.26 0.9 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.653 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -128.74 158.95 70.61 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.76 -13.79 28.38 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.976 2.451 . . . . 0.0 113.642 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -85.54 14.25 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.543 0.211 . . . . 0.0 111.076 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 28' ' ' SER . 94.5 mt-30 -94.08 123.12 37.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.937 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 98.6 t -98.85 122.76 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.483 171.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.5 m -89.66 116.37 27.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.393 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 25' ' ' LEU . 52.0 t -92.04 115.4 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.924 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -107.41 113.04 26.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.718 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.79 104.44 11.31 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 66' ' ' ASN . 96.9 mt -109.98 145.31 37.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.305 0.574 . . . . 0.0 112.434 -169.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.11 171.27 14.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.157 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -70.95 -32.85 69.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.507 0.67 . . . . 0.0 109.456 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -86.31 12.39 10.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.92 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 59.15 96.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.941 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.7 m -154.17 138.72 16.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.191 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 t -72.15 93.29 1.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.491 HG12 HG21 ' A' ' 42' ' ' ILE . 10.6 tp -75.33 -27.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.276 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.54 154.98 78.67 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.451 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -53.44 137.59 65.19 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.157 2.571 . . . . 0.0 112.982 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -70.09 132.42 45.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.995 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 42.6 mt -94.16 161.58 14.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.081 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -118.72 107.26 13.45 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.62 170.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 50.1 mt -89.15 102.77 15.43 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.638 ' HB3' ' HG2' ' A' ' 8' ' ' GLN . 12.9 p -116.05 122.08 44.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.491 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.5 -149.75 5.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 33' ' ' GLU . 63.2 mt -81.75 153.35 26.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -57.31 -47.37 81.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.271 0.557 . . . . 0.0 110.263 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -102.99 73.83 1.27 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.526 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 34.0 tt0 -136.75 120.89 17.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.069 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -72.04 112.25 7.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.522 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 53.9 p90 -104.83 166.02 10.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.275 0.559 . . . . 0.0 111.489 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -118.59 151.23 38.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.351 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' HD12 ' A' ' 54' ' ' ILE . 59.9 t -112.31 120.43 41.53 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.092 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.5 Cg_exo -69.96 118.28 5.59 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.147 2.565 . . . . 0.0 111.393 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -87.4 -39.83 14.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 64.83 167.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.294 0.569 . . . . 0.0 111.618 -175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -123.6 114.74 20.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.063 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 11.3 mm -84.96 159.95 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -66.37 91.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.54 -175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 74.78 51.8 7.66 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.508 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 24.5 m-85 -128.12 127.36 42.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.863 0.363 . . . . 0.0 110.625 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -92.87 137.16 32.61 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.765 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.87 108.59 5.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -56.86 -51.53 68.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.074 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 59.1 tttm 172.57 156.04 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.109 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HE1' HG12 ' A' ' 67' ' ' ILE . 7.6 m-85 -85.13 137.53 32.97 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.67 -26.39 63.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.3 p -160.42 173.38 15.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.883 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -73.16 140.98 47.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.037 0.446 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 37' ' ' VAL . 30.1 pt -101.83 -17.51 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.284 -176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -79.75 94.48 5.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.427 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -164.97 -169.04 28.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.723 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 35.0 m -98.56 163.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.63 0.253 . . . . 0.0 110.852 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.8 m-85 -70.35 -176.74 1.27 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.512 0.672 . . . . 0.0 111.541 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.8 m -152.31 158.96 43.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -85.5 41.61 0.91 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.852 0.834 . . . . 0.0 110.068 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.5 m -152.77 123.06 3.44 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.469 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 73.4 Cg_exo -49.61 108.17 0.19 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.055 2.503 . . . . 0.0 112.953 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 94.7 mt-30 -86.73 165.17 16.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.097 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 m -130.5 112.03 12.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.913 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.3 mm -92.26 105.51 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.446 ' HB2' HD12 ' A' ' 14' ' ' LEU . 18.8 p-10 -92.17 98.64 11.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.642 0.734 . . . . 0.0 111.032 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG12 ' HE1' ' A' ' 50' ' ' TYR . 45.1 mt -94.17 98.76 8.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.098 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.76 112.91 27.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.21 0.528 . . . . 0.0 111.189 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.707 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 36.4 m-85 -98.72 132.91 43.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.529 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -104.05 129.33 51.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.823 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -61.39 145.84 50.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.412 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 32.2 mmtp -64.31 -40.25 95.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.811 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 57.53 77.46 0.41 Allowed Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 109.694 -170.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.34 21.04 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.986 2.457 . . . . 0.0 113.707 -170.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -161.61 124.02 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -77.38 165.78 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.271 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.42 3.14 25.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.266 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.22 -21.01 46.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.496 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' HIS . 18.7 mm-40 -81.24 131.05 35.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.409 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 12.5 m-70 74.35 121.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 124.158 0.911 . . . . 0.0 111.175 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.09 122.54 29.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.741 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -119.33 159.23 24.54 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -75.7 -23.57 56.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.088 0.47 . . . . 0.0 110.289 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -112.96 133.49 54.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.817 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 m80 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.319 173.642 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.674 0.273 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -92.14 -45.69 8.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.201 0.524 . . . . 0.0 109.725 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 167.18 18.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.684 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.88 35.15 89.14 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 58.6 tttp -98.26 133.83 22.56 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.37 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 25.6 Cg_exo -63.19 111.83 1.54 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.452 2.101 . . . . 0.0 111.28 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -76.83 134.13 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 90.2 mt-30 -101.5 114.61 28.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.541 -173.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.06 108.1 19.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.581 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.7 m -90.79 112.86 24.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.002 0.429 . . . . 0.0 111.354 -174.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG21 ' HD2' ' A' ' 38' ' ' PRO . 59.2 t -87.79 108.78 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 24' ' ' SER . 26.7 t-20 -114.32 129.96 56.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.26 -174.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' SER . 70.8 m-85 -97.21 107.07 19.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.02 144.85 37.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.368 0.604 . . . . 0.0 112.622 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.87 172.52 13.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.127 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 18' ' ' ASN . 45.0 mt-10 -75.12 -25.07 58.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.748 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -76.25 1.18 16.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 16' ' ' GLU . 64.0 t30 60.53 80.54 0.21 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.839 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.4 m -153.36 133.35 13.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.055 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 30.6 m -66.25 98.41 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.186 0.517 . . . . 0.0 110.661 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.8 pt -79.27 -17.75 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.85 150.9 76.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.772 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.27 117.02 3.05 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.756 2.304 . . . . 0.0 112.033 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 12' ' ' ASN . 3.6 p -87.58 144.27 26.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.477 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -130.08 144.05 51.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.386 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 37.9 p90 -112.64 133.73 54.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.145 0.497 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 67.4 mt -86.55 118.98 26.32 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.961 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -96.41 93.2 6.7 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.19 -171.05 15.15 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.478 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.96 161.9 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.99 126.56 27.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.379 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.7 74.18 0.46 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.744 0.783 . . . . 0.0 110.602 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 40.2 tt0 -134.29 135.54 42.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.33 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -81.69 104.4 12.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.199 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -111.39 163.88 13.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.418 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -116.77 126.6 53.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.626 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 54' ' ' ILE . 6.7 p -79.69 116.89 64.17 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.023 0.44 . . . . 0.0 110.673 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.8 Cg_exo -73.37 100.43 1.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.52 2.146 . . . . 0.0 112.208 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 71.9 mtm -93.29 83.4 4.6 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -82.78 135.3 35.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.559 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -75.93 103.37 5.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.166 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.4 mt -72.11 115.05 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -56.7 117.56 4.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.602 0.715 . . . . 0.0 112.005 -168.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.55 23.85 17.64 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.12 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 79.2 m-85 -127.64 135.58 50.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 111.237 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 70' ' ' GLN . 52.3 m -90.88 148.75 22.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.039 176.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 68' ' ' ILE . 57.0 tp -80.6 -46.57 15.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.889 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.4 tt 70.68 -71.86 0.12 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -175.59 127.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.436 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -84.89 163.99 18.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.17 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 13.7 t70 -78.62 128.97 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.543 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.2 m 64.16 -172.45 0.17 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.73 0.644 . . . . 0.0 110.533 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -107.72 140.92 40.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 48.4 mt -86.31 100.75 9.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.146 -173.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.38 127.37 32.01 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -82.96 35.41 2.74 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.104 -0.57 . . . . 0.0 113.246 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 5.8 m -135.2 138.51 48.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 87.6 m-85 -70.69 103.8 2.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.119 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.7 p -82.49 -164.03 0.78 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.626 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.88 -25.69 56.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.126 0.489 . . . . 0.0 110.364 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.8 p -98.51 136.33 20.85 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.949 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.82 105.82 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.147 1.898 . . . . 0.0 109.985 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -85.85 115.95 23.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.463 -169.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -86.34 111.58 20.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 67' ' ' ILE . 61.0 mt -89.89 100.32 10.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 88.6 m-20 -80.32 87.05 5.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.337 -177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG13 HG22 ' A' ' 65' ' ' ILE . 68.3 mt -86.62 107.15 16.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.186 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 47' ' ' LEU . 74.3 mt -95.15 140.56 16.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.133 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 32.4 m-85 -120.39 128.57 53.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.465 0.65 . . . . 0.0 111.132 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 59.2 tt0 -91.09 137.39 32.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.324 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -65.26 113.26 3.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.8 -22.05 61.62 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.57 112.66 28.25 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.117 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.54 153.34 70.05 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.761 2.308 . . . . 0.0 112.441 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . 10.4 tp10 -57.51 -23.34 49.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.189 176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -55.39 -37.46 67.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.559 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.81 -25.01 13.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.965 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 52.4 tp -68.5 -36.97 79.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.327 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.606 ' OE2' ' HA ' ' A' ' 82' ' ' HIS . 28.9 tt0 -70.68 108.13 4.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -62.92 -46.42 87.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.119 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -109.96 97.25 6.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 1.4 t60 -72.05 122.8 21.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.141 -174.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -59.78 -48.67 80.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.419 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -90.72 91.3 8.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.813 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.635 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 71.4 t60 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.066 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -127.09 121.35 31.25 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -158.15 167.55 29.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.298 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.15 34.48 26.42 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 44.7 mtpt -130.7 129.82 22.77 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.79 0.328 . . . . 0.0 110.921 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 66.8 Cg_endo -90.87 106.84 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.937 2.425 . . . . 0.0 111.92 175.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.02 175.64 7.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.77 141.88 49.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.8 0.333 . . . . 0.0 111.321 -172.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 63' ' ' GLN . 18.0 m -120.11 127.89 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.573 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 p -89.15 114.78 26.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 99.2 t -91.12 110.51 22.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.081 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.41 HD22 ' CB ' ' A' ' 24' ' ' SER . 14.3 m120 -103.1 123.18 46.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.662 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -92.23 101.45 13.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 59.0 mt -108.88 151.69 25.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.562 0.696 . . . . 0.0 112.471 -169.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.7 -178.75 4.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.473 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -73.46 -25.51 60.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.345 0.593 . . . . 0.0 109.562 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -83.18 6.41 19.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.58 0.705 . . . . 0.0 109.12 169.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 16.2 m120 67.36 16.98 10.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.601 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 m -76.53 138.89 40.51 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.1 107.87 2.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.811 0.338 . . . . 0.0 110.389 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 36.9 pt -88.97 -17.2 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.266 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.76 154.83 78.24 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -58.12 109.0 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.535 2.157 . . . . 0.0 111.495 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.41 ' CB ' HD22 ' A' ' 12' ' ' ASN . 46.6 m -68.3 150.08 48.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 pp -127.31 162.97 25.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.326 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -119.19 113.47 20.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.079 0.466 . . . . 0.0 110.314 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . 97.0 mt -73.71 134.3 43.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.1 m -106.2 123.95 48.83 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.56 165.85 27.44 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 93.7 mt -81.1 157.22 25.44 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.03 128.6 38.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.389 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 69.06 26.51 5.59 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.446 0.641 . . . . 0.0 110.659 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 35.2 tt0 -106.5 139.79 40.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.082 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.06 37.21 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 46.5 p90 -131.11 156.57 45.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 0.0 111.352 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -124.37 115.78 21.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 p -82.46 132.12 53.44 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.923 0.392 . . . . 0.0 111.464 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 4.6 Cg_exo -78.32 111.96 3.12 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.731 2.288 . . . . 0.0 111.666 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.624 ' SD ' HD22 ' A' ' 47' ' ' LEU . 46.2 ttp -114.75 109.48 18.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -114.99 133.43 56.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -77.29 126.62 31.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -112.49 131.18 64.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.035 -167.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 41.8 tttp 61.51 30.41 18.76 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.951 0.782 . . . . 0.0 112.036 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 77.52 44.22 13.48 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.633 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 7.1 m-85 -105.01 175.02 5.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.823 0.344 . . . . 0.0 110.514 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.6 m -142.23 131.2 23.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD22 ' SD ' ' A' ' 39' ' ' MET . 29.4 tp -58.4 127.88 34.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.024 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.4 -54.02 6.34 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 58.5 tttm -178.88 159.46 1.04 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HE1' HG12 ' A' ' 67' ' ' ILE . 2.5 m-85 -85.11 139.61 31.59 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 172.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -23.83 28.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.314 0.578 . . . . 0.0 109.726 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 m -131.92 132.6 43.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.665 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.56 127.02 31.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.217 0.532 . . . . 0.0 110.043 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG21 HG11 ' A' ' 37' ' ' VAL . 41.8 pt -87.39 2.32 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.25 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.4 tp -91.21 14.45 14.26 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.0 -176.78 42.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.185 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.97 164.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.764 0.316 . . . . 0.0 111.068 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 4.1 m-85 -64.73 121.3 14.21 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.007 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.4 p -82.01 178.18 8.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.503 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.63 -43.35 23.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.173 0.511 . . . . 0.0 109.979 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.8 m -81.03 144.71 55.32 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.832 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.13 106.68 0.35 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 111.804 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 9' ' ' VAL . 29.8 tt0 -86.12 133.63 33.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.049 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.4 m -96.3 124.22 40.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.983 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 11' ' ' VAL . 38.6 mm -99.64 104.48 16.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.385 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -93.57 96.28 9.76 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.101 0.477 . . . . 0.0 110.439 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.456 HG12 ' HE1' ' A' ' 50' ' ' TYR . 37.3 mt -83.6 93.82 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.59 115.81 32.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.123 -173.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 73.3 m-85 -99.97 135.6 41.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.342 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -92.75 134.05 35.42 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -69.15 113.26 6.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 21.7 pttp -68.24 143.07 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.23 0.538 . . . . 0.0 110.661 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -97.0 172.83 4.59 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.184 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 5.4 Cg_endo -50.15 -39.98 51.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.158 1.906 . . . . 0.0 111.032 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 49.4 mt-10 49.5 79.04 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.212 0.945 . . . . 0.0 111.586 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.3 -1.11 56.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.888 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.58 167.35 16.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.743 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -101.1 6.66 43.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -80.15 -32.31 38.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.936 0.398 . . . . 0.0 109.993 175.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.3 147.44 22.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 167.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -109.3 96.84 6.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.68 0.752 . . . . 0.0 110.592 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -93.3 118.05 30.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.355 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -117.94 138.82 51.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.983 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -73.56 172.35 11.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.64 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.622 -0.704 . . . . 0.0 109.599 175.132 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.078 0.466 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.6 143.83 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -69.81 -42.46 73.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.4 5.81 57.81 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 10.2 mptt -128.75 123.38 22.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -81.55 -21.33 6.27 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.344 2.029 . . . . 0.0 113.089 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 57.13 29.0 15.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.449 0.642 . . . . 0.0 109.957 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 42.9 tt0 -81.45 107.47 14.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.332 -175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 63' ' ' GLN . 87.9 t -87.72 125.36 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.8 m -112.39 104.82 12.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.87 0.367 . . . . 0.0 110.524 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 65.7 t -90.35 110.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.695 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -101.17 129.37 47.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.533 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.04 95.96 10.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 66' ' ' ASN . 87.4 mt -98.9 140.6 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.656 0.741 . . . . 0.0 112.851 -168.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.3 171.27 11.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.486 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.93 -33.47 72.19 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -76.69 -3.21 36.77 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.15 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.8 t30 68.34 86.82 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.618 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.1 m -157.46 139.51 14.33 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 t -74.09 97.23 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.367 0.603 . . . . 0.0 109.82 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 42' ' ' ILE . 16.5 pt -77.49 -12.22 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.016 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.27 155.11 81.69 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.97 132.97 52.72 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.437 2.091 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 m -56.5 127.45 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.563 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.0 tp -89.52 109.92 20.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.332 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -90.72 109.08 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.273 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 39.2 tp -107.58 108.03 19.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.98 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -109.22 138.18 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.15 -158.74 9.08 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.533 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 80.8 mt -92.09 149.97 21.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HG2' ' A' ' 60' ' ' GLU . 75.6 t80 -65.8 136.33 56.05 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 7.3 t30 69.09 20.61 7.62 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.397 0.618 . . . . 0.0 110.509 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 51.6 tt0 -94.66 126.82 40.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -79.08 117.02 19.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.107 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.7 p90 -110.5 -177.64 3.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.155 0.503 . . . . 0.0 111.67 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -126.79 164.12 22.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.831 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HB ' HG23 ' A' ' 54' ' ' ILE . 72.0 t -120.79 100.63 46.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.88 0.372 . . . . 0.0 110.698 -178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG2' HD21 ' A' ' 25' ' ' LEU . 43.5 Cg_endo -73.06 100.89 1.27 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.332 2.022 . . . . 0.0 111.745 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.6 mtm -82.64 155.69 24.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.401 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -118.71 168.86 10.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.9 125.01 43.88 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.567 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.466 HG13 HD12 ' A' ' 21' ' ' ILE . 23.8 mm -95.41 163.79 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -56.05 101.31 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 29.82 55.81 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.444 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -113.78 136.06 53.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.569 . . . . 0.0 110.972 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.1 m -118.63 147.87 43.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.968 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.9 tp -72.58 135.56 45.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.245 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.9 tp -78.62 -61.66 1.94 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.3 tttm 164.82 162.36 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.549 177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.56 140.4 49.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -74.64 -57.45 3.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.975 0.417 . . . . 0.0 110.239 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 m -64.57 134.19 53.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.105 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.0 123.46 18.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 37' ' ' VAL . 40.7 mm -59.9 -36.49 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.529 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.97 93.33 5.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.233 0.539 . . . . 0.0 110.102 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -139.25 176.9 20.72 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.551 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 33' ' ' GLU . 29.2 m -107.83 152.82 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.576 0.188 . . . . 0.0 110.751 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 90.9 m-85 -64.3 136.44 57.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.256 175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.2 p -116.29 162.01 18.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.354 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 6.3 mm-40 -52.41 -53.23 47.76 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.895 0.747 . . . . 0.0 110.789 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.6 p -85.25 151.65 57.01 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.474 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 52.9 Cg_exo -53.37 113.36 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.729 2.286 . . . . 0.0 112.046 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 9' ' ' VAL . 7.6 tt0 -89.1 117.79 28.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.705 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -98.85 115.28 28.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.178 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.2 mt -104.09 108.43 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 14' ' ' LEU . 92.7 m-20 -90.72 100.54 13.37 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.825 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.26 104.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.352 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.15 126.54 51.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.207 0.527 . . . . 0.0 111.101 -172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -105.35 145.67 30.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.003 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -109.49 156.51 20.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.164 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 56.3 mttt -93.1 150.42 20.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.089 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -82.14 54.41 2.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.47 0.652 . . . . 0.0 110.454 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . -141.25 -51.52 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.462 174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 15.1 Cg_exo -70.35 109.65 2.48 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.977 1.785 . . . . 0.0 110.629 168.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -76.77 127.17 32.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -76.98 124.79 28.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.981 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.39 -30.59 62.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 111.378 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.0 mt -92.88 95.73 9.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.279 0.561 . . . . 0.0 110.994 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' ' HA ' ' A' ' 81' ' ' HIS . 5.5 tm-20 -62.21 129.07 39.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.273 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 32.6 m170 -60.26 -17.83 44.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.826 0.346 . . . . 0.0 111.652 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.479 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 4.2 m-70 78.85 75.64 0.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.284 1.034 . . . . 0.0 111.862 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -95.52 -5.14 43.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.437 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -134.96 142.6 46.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.597 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -95.95 -46.07 6.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.01 176.389 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.414 0.15 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.23 152.35 29.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.602 0.239 . . . . 0.0 110.807 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.72 -33.44 25.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.21 -120.31 3.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.173 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.626 ' HD2' ' HB2' ' A' ' 60' ' ' GLU . 29.2 mttp -130.8 131.15 23.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 5.7 Cg_exo -79.05 121.66 5.01 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 123.007 2.471 . . . . 0.0 112.157 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -76.24 74.28 3.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 111.778 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.36 117.2 23.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.806 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 70.3 t -86.72 119.74 35.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 110.041 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 m -89.4 98.65 11.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.54 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 60.6 t -90.82 116.98 33.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.765 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.475 HD22 ' C ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -123.08 137.13 55.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.291 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -105.67 114.48 28.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.535 HD12 HG12 ' A' ' 68' ' ' ILE . 60.8 mt -98.23 155.94 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 111.4 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 17.4 p-10 -88.32 -40.14 13.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.85 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 16.3 tt0 155.28 -30.73 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.266 1.426 . . . . 0.0 107.319 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 28.7 m-80 -98.88 15.51 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.079 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.5 m-80 70.06 24.67 4.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.066 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 m -90.24 116.8 28.49 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -70.29 97.17 1.2 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 15' ' ' ASP . 18.2 pt -69.79 -21.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.772 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.49 149.36 61.41 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.125 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.49 154.88 39.14 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.646 2.23 . . . . 0.0 112.371 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -62.25 114.2 3.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.496 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 63.6 tp -90.29 114.3 26.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.171 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -94.88 102.38 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 63.3 tp -87.29 103.15 15.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.835 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -111.15 134.31 52.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.583 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.87 -142.09 3.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 70.4 mt -104.75 142.9 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -63.07 138.57 58.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.021 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.95 3.41 4.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.004 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -100.94 137.16 39.69 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.945 -0.472 . . . . 0.0 109.805 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -70.71 150.1 46.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 26.7 p90 -132.15 167.12 20.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.209 0.528 . . . . 0.0 111.338 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -121.69 131.45 54.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.859 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 54' ' ' ILE . 65.3 t -99.11 119.46 60.65 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.678 -178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 14.4 Cg_exo -68.94 123.86 10.81 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 94.2 mmm -83.13 -51.58 7.39 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 70.32 143.22 0.05 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.777 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -82.51 94.86 7.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 22.7 mt -73.65 141.37 16.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.08 95.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.86 36.57 28.26 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.299 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 61.8 m-85 -123.59 133.81 53.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 111.317 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 72' ' ' LYS . 52.3 m -102.35 139.61 37.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.41 113.49 6.03 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.191 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 64.0 tp -71.13 -51.21 26.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.752 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 176.61 138.19 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.923 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -114.81 130.7 56.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 166.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.06 -64.91 0.79 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.4 m -115.32 164.9 13.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.673 0.273 . . . . 0.0 111.094 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -57.79 130.35 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.914 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 37' ' ' VAL . 31.3 pt -80.84 -10.68 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.806 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -84.57 112.75 20.71 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.75 -171.98 27.43 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.12 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 35.0 m -113.66 154.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.2 m-85 -69.4 98.53 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.206 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -86.63 175.32 8.36 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 21.7 mt-10 -67.63 -36.65 81.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.179 0.514 . . . . 0.0 109.868 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 m -69.65 121.36 82.19 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.757 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.03 105.91 0.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.439 2.093 . . . . 0.0 111.067 175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -85.6 122.38 29.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.577 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.8 m -96.13 105.69 17.77 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.461 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 54' ' ' ILE . 51.0 mt -98.68 96.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.153 0.502 . . . . 0.0 109.899 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -84.21 93.48 8.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.763 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.5 mt -82.18 118.43 29.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.278 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.535 HG12 HD12 ' A' ' 14' ' ' LEU . 53.9 mt -101.71 112.74 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.196 0.522 . . . . 0.0 111.186 -171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -96.17 -178.02 4.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.554 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 47.3 tt0 -150.94 124.89 9.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -67.17 135.07 52.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.191 -0.603 . . . . 0.0 110.27 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 52.7 mttm -68.38 -14.61 63.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.159 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . 67.15 112.98 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.84 0.713 . . . . 0.0 111.151 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 16.8 Cg_exo -66.56 101.71 0.56 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.775 2.317 . . . . 0.0 112.484 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -100.74 151.03 22.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.52 -35.73 81.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.965 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.31 -176.76 0.2 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 123.993 0.808 . . . . 0.0 110.916 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.18 93.09 4.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.684 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 37.7 tt0 -64.86 138.55 58.44 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -74.58 -3.73 32.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 0.0 110.461 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.684 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 38.5 m80 -116.54 134.12 55.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.22 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -73.0 -33.3 65.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -121.32 118.52 29.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.085 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 85' ' ' HIS . 77.6 t60 -54.85 -36.36 64.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.835 -169.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 35.3 t-80 . . . . . 0 C--O 1.246 0.905 0 O-C-N 123.433 0.458 . . . . 0.0 110.022 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -122.37 -179.73 4.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.754 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.53 155.52 21.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.386 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.07 -99.26 1.96 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.292 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -127.7 154.88 77.87 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.53 -30.37 61.36 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.912 2.408 . . . . 0.0 112.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -93.5 15.18 16.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 111.008 -178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -91.91 116.11 28.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.4 t -87.39 130.78 36.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.172 0.51 . . . . 0.0 110.192 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 m -105.9 102.55 11.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.824 -176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.5 t -87.65 121.82 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.591 ' ND2' HD21 ' A' ' 14' ' ' LEU . 57.5 t30 -123.5 119.57 30.36 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.904 0.383 . . . . 0.0 110.13 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CD1' ' HE2' ' A' ' 69' ' ' TYR . 67.7 m-85 -90.81 110.47 21.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.421 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.591 HD21 ' ND2' ' A' ' 12' ' ' ASN . 70.0 mt -109.84 -178.05 3.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.7 0.762 . . . . 0.0 112.726 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' CG ' ' N ' ' A' ' 16' ' ' GLU . 1.1 t70 -137.97 177.24 8.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.264 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' A' ' 15' ' ' ASP . 44.4 mt-10 -65.6 -34.03 77.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.166 0.508 . . . . 0.0 110.3 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.46 8.25 14.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.11 30.67 20.11 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.888 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -75.81 127.52 33.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -72.27 95.72 1.74 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 pt -82.05 -21.75 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.457 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.77 148.61 66.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.902 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.82 142.6 83.46 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.567 2.178 . . . . 0.0 111.64 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -60.96 133.37 56.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.145 0.498 . . . . 0.0 110.551 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -99.51 106.48 18.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.724 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -81.07 110.6 16.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.826 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.13 95.73 6.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.994 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.1 m -102.17 146.04 28.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.0 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.82 -157.76 8.68 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.703 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 61.9 tp -80.74 142.04 34.21 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 77.5 t80 -63.53 135.58 56.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 72.58 12.98 5.41 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.813 0.695 . . . . 0.0 111.073 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 39.8 tt0 -92.43 140.88 29.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.265 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 117.86 24.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 33.4 p90 -99.81 163.31 12.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.299 0.571 . . . . 0.0 111.747 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -114.78 130.27 56.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.621 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 54' ' ' ILE . 6.6 p -94.78 114.52 63.75 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.185 0.517 . . . . 0.0 110.646 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.6 Cg_exo -73.84 117.56 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.791 2.328 . . . . 0.0 112.051 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.0 ttm -85.44 114.14 22.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -90.81 140.86 29.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.629 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -89.47 97.5 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -80.62 142.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.01 103.7 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.28 33.38 61.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.423 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 78.1 m-85 -118.28 124.15 47.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.048 0.451 . . . . 0.0 110.567 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.3 m -106.62 132.57 52.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.79 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.6 tp -62.3 124.25 20.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.09 0.471 . . . . 0.0 110.913 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 55.8 tp -80.85 -52.59 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 49' ' ' LYS . 34.5 ttpt 173.84 159.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.716 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.41 145.01 25.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.843 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 15.9 t70 -91.82 -21.29 20.73 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 175.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 m -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.357 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.7 129.78 41.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 110.462 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 29.1 pt -87.5 43.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.023 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.6 mt -126.24 98.95 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.462 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.62 45.48 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.518 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.89 168.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 94.1 m-85 -65.34 108.52 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.309 . . . . 0.0 110.926 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 p -100.36 -174.14 2.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.828 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 48.6 mt-10 -87.87 24.97 1.63 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.288 0.566 . . . . 0.0 110.428 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -134.08 121.42 15.65 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.929 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.4 106.63 0.25 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.609 2.206 . . . . 0.0 111.461 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.04 111.09 19.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.279 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.9 m -87.78 107.49 18.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.234 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 59.3 mt -91.74 105.19 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.971 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.843 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 94.3 m-20 -84.84 104.4 14.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.203 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.97 108.7 24.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 14' ' ' LEU . 85.7 mt -97.2 116.41 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.117 0.484 . . . . 0.0 111.353 -172.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 84.7 m-85 -102.23 138.73 38.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.544 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -97.21 131.2 44.17 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -66.47 118.6 10.33 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -52.21 -41.97 63.14 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.324 0.39 . . . . 0.0 111.921 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . 62.65 -179.77 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 O-C-N 123.786 0.679 . . . . 0.0 110.065 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 33.4 Cg_exo -61.23 99.21 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.506 1.471 . . . . 0.0 111.558 172.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -65.22 123.3 19.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 63.78 69.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.884 0.74 . . . . 0.0 109.906 -170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 174.86 8.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.996 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.63 19.97 1.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.121 0.486 . . . . 0.0 110.948 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -119.91 134.74 55.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.422 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.56 101.22 9.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -74.48 129.01 36.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.257 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -82.75 -10.06 59.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.917 -172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -135.26 115.03 12.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.412 0.625 . . . . 0.0 111.992 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -122.13 -25.75 4.85 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.596 174.867 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.778 0.323 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -93.32 129.5 39.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.559 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -127.74 139.12 52.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.83 -171.43 46.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.196 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -106.56 114.86 61.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.948 0.374 . . . . 0.0 110.23 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.58 106.25 0.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.254 1.97 . . . . 0.0 110.755 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -70.64 116.81 11.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.942 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 47.5 mt-30 -110.68 116.7 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.54 -172.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 63' ' ' GLN . 97.1 t -98.82 114.01 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.315 173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 m -91.25 110.32 21.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 93.7 t -87.47 113.67 25.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.684 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -102.28 117.44 34.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.489 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 97.1 m-85 -86.35 89.38 7.85 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.525 175.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.457 HD13 ' OD1' ' A' ' 18' ' ' ASN . 69.8 mt -92.5 160.29 15.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.483 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.85 118.78 8.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.058 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 39.3 tt0 54.72 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.545 1.153 . . . . 0.0 113.644 168.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.76 14.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.091 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.457 ' OD1' HD13 ' A' ' 14' ' ' LEU . 65.6 t30 71.67 21.55 4.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.613 0.721 . . . . 0.0 110.342 175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.1 m -98.11 138.96 34.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.157 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -76.32 109.82 10.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.982 0.42 . . . . 0.0 110.478 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.68 -11.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.281 0.562 . . . . 0.0 110.612 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -133.39 141.29 39.9 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.354 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.2 138.35 63.61 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.945 2.43 . . . . 0.0 112.24 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -58.79 130.68 48.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.334 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 61.9 tp -95.84 106.21 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.451 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -98.68 112.26 24.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.389 0.614 . . . . 0.0 111.122 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 95.0 mt -87.15 120.32 28.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.388 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 t -100.13 116.29 31.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.692 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.12 -173.47 16.41 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.733 -178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 91.5 mt -97.47 168.08 10.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -62.8 135.94 57.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.796 0.331 . . . . 0.0 111.623 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 69.44 12.51 8.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.383 173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -82.74 129.87 35.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.031 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.42 127.64 33.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.489 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 20.3 p90 -112.0 165.16 12.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -114.69 131.39 56.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.899 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.6 t -105.93 111.91 64.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.337 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 3.2 Cg_exo -82.13 114.16 2.49 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.034 2.49 . . . . 0.0 111.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.5 mtt -69.14 -57.72 5.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.058 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 62.68 115.12 0.02 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.364 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -70.74 113.0 7.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.97 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -78.96 154.67 4.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -66.96 92.33 0.23 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.71 40.0 6.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.521 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 95.9 m-85 -133.93 119.32 18.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.977 0.417 . . . . 0.0 110.61 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.6 m -89.59 127.54 35.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 50' ' ' TYR . 53.4 tp -58.29 119.05 6.21 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.862 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.73 -51.58 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.458 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.7 tttp 179.34 156.66 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' HG12 ' A' ' 67' ' ' ILE . 7.0 m-85 -108.58 146.99 32.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.213 172.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -73.58 -61.86 1.69 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.785 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.2 t -107.01 -162.1 0.82 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.962 177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.66 -176.78 4.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.966 0.412 . . . . 0.0 110.444 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -93.5 -60.48 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -85.09 147.78 26.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.884 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.81 -166.25 30.23 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.67 149.52 24.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 93.2 m-85 -61.96 118.17 6.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.832 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 p -89.36 170.96 10.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.464 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -80.35 40.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 111.185 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 p -158.15 152.01 19.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.02 104.82 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.578 1.519 . . . . 0.0 110.192 174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' HG22 ' A' ' 9' ' ' VAL . 50.5 tt0 -93.16 138.36 31.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.008 -172.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -113.74 127.72 56.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.799 0.333 . . . . 0.0 111.333 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -111.14 108.53 25.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.58 101.58 14.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.275 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 50' ' ' TYR . 38.8 mt -98.84 93.82 3.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 14' ' ' LEU . 55.3 mt -93.58 120.54 43.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -172.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 64.4 m-85 -100.11 161.53 13.55 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.861 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -126.73 110.8 13.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.004 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 74' ' ' PRO . 8.7 ptpp? -49.95 136.75 18.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.913 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -54.49 -40.72 68.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.22 94.15 3.73 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 57.2 Cg_endo -68.66 157.85 60.15 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.947 2.431 . . . . 0.0 113.689 -169.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 47.8 mt-10 -111.27 -167.04 1.13 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.39 174.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 63.89 13.31 7.47 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -170.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.08 -165.81 1.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.765 -171.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.12 -57.19 4.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.323 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.28 77.36 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.528 0.68 . . . . 0.0 111.754 -170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -162.44 -40.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -93.2 160.82 14.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.375 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.34 153.46 47.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -68.1 -34.41 76.35 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.025 -174.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -82.72 -14.3 54.8 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.063 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.633 -177.19 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.9 mtm . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -93.28 145.15 24.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.93 -10.83 56.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.786 0.327 . . . . 0.0 110.99 -175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.81 54.1 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.182 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 55.9 mttp -122.64 107.59 33.87 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 16.7 Cg_exo -67.84 -39.52 11.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.989 2.459 . . . . 0.0 112.063 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -80.68 57.98 3.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.459 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 49.7 tt0 -112.88 100.21 8.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 0.0 111.149 -177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.53 113.23 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.3 m -99.68 107.1 19.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.368 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 59.1 t -93.38 116.73 35.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -113.75 123.69 50.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.115 0.484 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -89.99 103.86 16.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.138 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -103.14 154.32 19.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.538 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.81 -60.7 2.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.691 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 177.35 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.746 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -84.11 28.24 0.62 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.2 m120 71.59 -0.83 3.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.691 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 m -71.94 122.78 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 t -83.6 108.2 16.55 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.453 HD12 HD12 ' A' ' 42' ' ' ILE . 26.2 pt -71.26 -17.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.454 0.645 . . . . 0.0 110.533 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.25 139.99 35.89 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.967 173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.92 148.06 39.74 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.06 2.507 . . . . 0.0 112.381 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -51.72 124.63 12.84 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 58.8 tp -89.67 118.82 29.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.806 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -86.62 91.76 8.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.365 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 53.6 tp -90.86 95.9 10.36 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 t -119.14 132.58 55.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.495 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.99 -140.01 3.84 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.91 154.44 18.67 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 81.6 t80 -65.16 133.64 51.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t30 59.34 76.22 0.37 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.502 0.668 . . . . 0.0 110.03 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.69 121.99 6.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.572 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -66.17 119.75 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.519 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 55.3 p90 -115.28 175.42 5.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.334 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -131.39 145.06 51.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.565 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 92.4 t -93.64 118.18 67.42 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.65 0.262 . . . . 0.0 110.592 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 22.7 Cg_exo -65.57 129.42 22.39 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.121 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -99.73 100.52 11.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.793 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 137.05 33.11 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -121.72 115.56 22.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.464 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 45' ' ' TYR . 38.3 mt -91.89 159.87 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -46.03 108.07 0.12 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.483 0.489 . . . . 0.0 112.141 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.55 54.67 7.34 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.908 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB ' ' A' ' 42' ' ' ILE . 41.0 m-85 -137.13 114.98 11.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.489 0.661 . . . . 0.0 111.155 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -98.66 137.08 37.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.775 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.56 113.8 5.03 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 57.2 tp -61.3 -54.95 37.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 15.2 ttpp 168.37 145.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 123.999 0.812 . . . . 0.0 109.369 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -119.48 111.05 17.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -78.12 -35.36 49.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.325 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.9 m -73.35 114.83 12.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.006 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -59.1 125.21 22.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.938 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 pt -88.54 -14.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.952 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.9 tp -75.1 106.01 6.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.334 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -178.92 -166.78 35.48 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.327 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.62 156.35 7.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.648 -0.13 . . . . 0.0 110.648 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 60.8 m-85 -56.03 126.64 26.8 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.613 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.18 159.98 27.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.356 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . 41.2 tt0 -88.67 -1.83 58.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.664 0.745 . . . . 0.0 109.984 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.4 m -122.28 145.95 45.68 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.309 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 12.2 Cg_endo -56.51 105.08 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.597 2.198 . . . . 0.0 111.816 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -101.37 113.85 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.936 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -89.06 121.38 31.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.375 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.9 mt -105.42 122.29 58.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -85.06 99.12 10.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.257 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.53 99.8 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.4 mt -94.42 123.31 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.176 -172.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -107.48 134.8 49.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.208 0.528 . . . . 0.0 111.015 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -100.03 130.32 46.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.529 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 112.14 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.404 0.621 . . . . 0.0 110.886 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -71.23 -33.32 69.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.301 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.72 96.4 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.295 0 O-C-N 123.924 0.765 . . . . 0.0 111.993 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.94 -28.77 28.86 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.778 2.319 . . . . 0.0 111.547 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -71.92 120.15 17.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.359 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -83.57 -68.51 0.71 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.218 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.81 -79.8 0.24 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.87 148.02 33.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.913 0.387 . . . . 0.0 111.229 -173.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.44 109.69 4.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.287 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -78.87 92.77 4.92 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.096 0.474 . . . . 0.0 109.737 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.31 132.55 47.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -71.17 -12.77 61.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.643 0.259 . . . . 0.0 111.63 -170.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -84.05 -3.39 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.498 0.666 . . . . 0.0 109.392 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.48 167.77 10.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.335 -177.767 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 72.6 mtm . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.832 0.349 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -104.76 108.52 20.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.748 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 1' ' ' MET . 99.1 m-85 -100.78 100.77 11.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.686 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -70.41 151.2 49.44 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -91.04 111.73 49.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 117.175 0.487 . . . . 0.0 111.255 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 4.9 Cg_exo -80.9 -21.93 6.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 172.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -82.51 75.35 9.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -141.27 145.5 35.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.993 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -112.1 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.4 m -100.15 110.85 23.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.678 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.0 t -87.69 123.31 40.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.926 0.393 . . . . 0.0 110.452 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -105.45 110.64 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.464 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 81.8 m-85 -84.47 98.98 10.4 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 62.7 mt -101.05 155.4 18.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.863 0.363 . . . . 0.0 111.364 -172.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 10.9 t70 -88.3 -164.97 1.2 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -78.73 -28.53 45.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.395 0.617 . . . . 0.0 109.346 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' A' ' 15' ' ' ASP . 33.2 p-10 -77.65 -1.09 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 94.3 m-20 69.74 19.86 7.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.436 172.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -90.15 140.65 29.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -63.55 108.55 1.4 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.144 0.497 . . . . 0.0 111.502 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 15' ' ' ASP . 21.4 pt -76.46 -33.28 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -112.36 156.73 41.71 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.482 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.31 147.91 82.24 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.552 2.168 . . . . 0.0 112.162 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 p -63.51 121.27 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 1.4 tm? -88.9 106.83 18.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.966 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -87.11 96.99 10.5 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.322 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.42 131.14 34.71 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.0 p -103.36 156.85 17.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.17 169.79 36.04 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 33' ' ' GLU . 80.9 mt -90.38 -179.09 5.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.05 140.22 57.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 t30 66.5 28.97 9.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.956 0.884 . . . . 0.0 110.125 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.62 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 9.6 tp10 -81.79 118.21 22.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.275 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.55 112.6 20.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -116.31 169.37 9.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.216 0.531 . . . . 0.0 112.229 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -115.0 127.71 55.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.675 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG21 ' HB ' ' A' ' 54' ' ' ILE . 36.7 t -83.04 114.47 52.93 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.2 Cg_exo -79.44 128.12 7.76 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.993 2.462 . . . . 0.0 112.502 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.4 mtt -104.09 153.83 20.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.63 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -139.9 121.5 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.809 0.338 . . . . 0.0 110.444 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.8 91.77 5.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.209 0.528 . . . . 0.0 110.665 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 22' ' ' ALA . 71.8 mt -77.79 119.99 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.537 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 63.22 16.5 9.47 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.542 0.526 . . . . 0.0 111.043 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.35 69.6 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.32 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -46.77 139.75 5.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.098 0.475 . . . . 0.0 111.845 179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.2 m -91.36 117.75 29.93 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.167 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.5 tp -63.08 123.8 19.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 54.7 tp -65.39 -59.92 3.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 82.9 tttt 153.17 154.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 125.208 1.567 . . . . 0.0 109.058 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -92.3 136.74 32.95 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 168.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -86.21 -14.33 44.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.644 -171.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 t -130.2 141.51 50.64 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -59.77 132.75 54.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.153 0.501 . . . . 0.0 111.168 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.6 ' HB ' HG21 ' A' ' 37' ' ' VAL . 21.3 pt -94.87 -17.62 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.844 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.72 98.7 2.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.057 0.456 . . . . 0.0 110.364 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.08 -161.01 10.03 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.33 152.18 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.602 0.239 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 21.8 m-85 -57.46 127.53 32.47 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 179.02 4.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.469 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.49 7.61 11.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.064 0.459 . . . . 0.0 110.981 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 p -121.08 130.83 24.67 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.917 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 37.9 Cg_exo -59.66 112.61 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.722 2.282 . . . . 0.0 111.746 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.59 142.04 33.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.142 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -125.32 131.69 52.99 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.117 0.484 . . . . 0.0 110.415 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.92 113.98 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.25 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -86.05 94.85 9.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.693 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 mt -95.41 99.3 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -92.12 114.4 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.558 -173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 51.3 m-85 -99.85 129.41 45.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.738 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -91.08 139.61 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -66.4 108.91 2.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -68.96 139.07 55.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.093 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.98 145.01 45.57 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.396 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HB3' HD23 ' A' ' 78' ' ' LEU . 51.9 Cg_exo -55.63 125.9 20.66 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.392 2.061 . . . . 0.0 111.397 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.25 168.57 8.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.75 -11.17 53.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.1 0.476 . . . . 0.0 110.815 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.1 -8.12 58.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 74' ' ' PRO . 48.6 tp -114.87 124.6 52.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.045 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -107.21 163.57 12.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.304 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -74.84 -40.69 60.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.804 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -132.92 146.3 51.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -113.88 163.78 14.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.579 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -82.86 -19.54 37.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.96 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -97.97 -8.58 27.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.386 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -67.4 -42.09 83.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -129.43 154.6 46.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.353 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.59 -25.85 66.75 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.633 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -134.12 96.05 16.25 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.356 0.598 . . . . 0.0 110.379 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HB2' ' HG3' ' A' ' 8' ' ' GLN . 83.1 Cg_endo -88.08 -2.22 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.875 2.383 . . . . 0.0 113.744 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' A' ' 60' ' ' GLU . 69.4 m-20 56.98 42.53 26.04 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.0 0.428 . . . . 0.0 110.645 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 6' ' ' PRO . 94.4 mt-30 -90.06 115.6 27.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.531 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 71.8 t -92.69 121.79 43.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -109.02 105.85 15.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.953 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 67.7 t -91.33 115.0 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.087 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -111.61 125.08 53.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.86 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 89.2 m-85 -93.83 105.72 17.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.359 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 66.2 mt -101.93 134.9 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 0.0 111.01 -177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 21' ' ' ILE . 23.7 t70 -103.15 95.17 5.94 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.011 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 58.17 -74.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.266 1.026 . . . . 0.0 113.188 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -80.67 24.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.52 0.328 . . . . 0.0 110.985 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 87.7 m-20 65.32 25.71 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.546 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.0 m -91.48 120.23 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.324 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 32.6 m -66.35 114.65 5.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.347 . . . . 0.0 110.764 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 15' ' ' ASP . 18.7 pt -100.6 -16.78 7.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 0.0 111.455 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -121.8 155.24 60.5 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.221 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.62 148.38 87.79 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.793 2.329 . . . . 0.0 112.181 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -66.88 118.08 9.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.876 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 64.4 tp -90.01 106.6 18.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.12 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.93 110.45 21.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.727 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 35' ' ' TYR . 46.1 tp -105.12 98.47 8.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.583 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -101.07 128.7 47.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.35 -151.63 5.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.278 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 95.7 mt -112.67 163.33 14.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.506 0.193 . . . . 0.0 110.536 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -59.97 122.06 13.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.18 22.79 13.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.519 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -84.85 146.63 27.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . . . -78.05 138.92 39.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.073 0.463 . . . . 0.0 111.338 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' HB2' HD21 ' A' ' 27' ' ' LEU . 49.1 p90 -138.21 158.55 44.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.962 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 83.9 m-20 -96.87 141.42 30.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.035 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.3 100.49 18.23 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HE3' ' A' ' 40' ' ' LYS . 3.5 Cg_exo -76.56 101.35 1.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.848 2.366 . . . . 0.0 112.335 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 66.4 mtt -72.5 -59.06 2.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 38' ' ' PRO . 8.4 mtmp? 71.14 156.87 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.498 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -77.94 112.92 15.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.441 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 43' ' ' LYS . 6.7 mt -96.75 171.46 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' H ' HG22 ' A' ' 42' ' ' ILE . 49.6 tttp -65.92 82.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.38 60.98 7.94 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.554 172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 71' ' ' LYS . 31.5 m-85 -125.2 141.17 52.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.312 0.577 . . . . 0.0 111.538 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 1.3 m -110.08 129.13 55.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.947 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.3 tp -64.85 124.68 22.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.391 . . . . 0.0 110.517 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.84 -44.48 8.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.161 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 50' ' ' TYR . 60.7 tttm 176.3 159.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.528 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' N ' ' HG2' ' A' ' 49' ' ' LYS . 31.4 p90 -129.39 148.24 51.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 52' ' ' SER . 0.9 OUTLIER -122.62 82.95 2.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.702 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 65' ' ' ILE . 7.7 t 173.42 -172.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.364 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -107.05 104.09 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.927 0.394 . . . . 0.0 110.757 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.2 pt -98.25 33.34 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.298 0.571 . . . . 0.0 110.12 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.25 -63.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.665 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . 144.97 42.15 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.049 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.81 122.07 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.348 . . . . 0.0 110.932 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 75.4 m-85 -72.07 128.48 35.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.425 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 19.8 p -94.14 152.65 18.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 7' ' ' ASN . 46.9 mt-10 -64.54 -43.01 95.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 m -82.37 151.37 65.65 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.77 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.61 116.46 2.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.044 2.496 . . . . 0.0 112.571 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' OG1' ' A' ' 59' ' ' THR . 34.1 tt0 -90.86 109.42 20.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.996 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -91.46 113.07 25.24 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 52' ' ' SER . 36.9 mt -103.59 100.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.353 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -84.28 102.68 12.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.126 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 65' ' ' ILE . 58.8 mt -102.95 113.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.3 122.52 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.059 -173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -102.08 146.72 27.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.874 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.17 136.01 33.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HG3' ' HE1' ' A' ' 45' ' ' TYR . 13.1 tttp -75.81 107.18 7.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.535 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 40.5 mtmt -74.24 90.69 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 112.81 32.37 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.674 0.273 . . . . 0.0 111.61 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 72' ' ' LYS . 81.3 Cg_endo -80.48 -18.71 9.38 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.592 2.195 . . . . 0.0 111.388 176.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -89.18 88.8 7.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.886 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -99.13 150.28 22.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.067 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.66 -16.65 63.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.056 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.9 tp -67.7 -62.87 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.537 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -94.52 108.98 20.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.918 0.39 . . . . 0.0 110.054 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.43 131.85 43.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.812 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -111.61 122.33 47.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 110.817 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -68.23 -33.91 75.26 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -95.62 61.23 2.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -66.17 132.49 48.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.076 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.345 179.569 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.5 mtp . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.773 0.32 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -93.44 -15.32 25.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.819 0.342 . . . . 0.0 110.848 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -93.43 11.67 27.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.6 36.74 3.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.157 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 63.0 mttp -65.76 -42.08 51.84 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 17.3 Cg_exo -69.98 46.71 0.54 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.258 1.972 . . . . 0.0 112.33 173.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' THR . 65.8 t30 -172.47 54.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -111.72 126.9 55.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.578 -170.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 93.0 t -103.82 124.38 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 168.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -107.85 106.15 16.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.872 0.367 . . . . 0.0 111.493 -173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 46.2 t -87.61 111.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' HD21 ' A' ' 14' ' ' LEU . 58.2 t30 -109.62 112.37 24.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -172.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 77.0 m-85 -89.54 106.94 18.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.516 -176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD21 ' ND2' ' A' ' 12' ' ' ASN . 65.0 mt -101.9 153.2 20.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.357 0.598 . . . . 0.0 111.315 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.06 -173.84 3.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.412 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.2 -34.2 77.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -74.45 0.13 15.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.439 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 13.0 m120 59.77 26.52 15.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.258 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -94.92 140.95 29.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.69 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.3 p -65.62 99.22 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.255 0.55 . . . . 0.0 110.787 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 pt -89.07 -21.87 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.73 153.5 46.86 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.67 132.25 50.44 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.639 2.226 . . . . 0.0 112.124 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.8 m -62.35 118.68 7.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.144 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 62.8 tp -89.7 112.42 23.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.242 -174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -97.83 105.57 17.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.44 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 97.0 mt -90.17 111.86 23.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.068 0.461 . . . . 0.0 109.862 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -133.9 115.33 14.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.108 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.92 -116.03 0.77 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.909 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.99 149.25 28.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.656 0.265 . . . . 0.0 110.328 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -76.58 134.62 39.33 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 61.21 91.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.441 0.639 . . . . 0.0 111.112 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CD1' ' A' ' 58' ' ' PHE . 35.2 tt0 -153.91 137.97 16.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.015 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.78 116.57 20.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.021 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -102.73 166.0 10.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.742 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -108.23 134.36 51.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.561 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 ' HB ' ' A' ' 54' ' ' ILE . 58.1 t -93.6 119.35 67.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.597 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 15.2 Cg_exo -68.24 122.2 9.23 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.893 2.396 . . . . 0.0 112.323 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 mtt -125.29 124.9 42.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.848 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.17 146.79 51.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.869 0.366 . . . . 0.0 111.406 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -86.94 92.6 9.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 170.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.34 106.09 17.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.715 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 61.6 26.97 16.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.709 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . . . 86.75 42.55 6.37 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.673 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -93.53 131.68 38.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.032 0.444 . . . . 0.0 110.359 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m -107.3 134.53 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.652 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.16 111.45 6.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 40.9 tp -60.14 -53.48 57.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 84.9 tttt 168.08 156.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.184 174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HB3' HD13 ' A' ' 67' ' ' ILE . 5.2 p90 -84.72 122.55 29.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.249 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.96 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 4.1 t70 -60.45 -40.58 91.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.3 m -110.45 148.0 32.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.798 ' HG2' ' H ' ' A' ' 55' ' ' LEU . 40.7 tt0 -61.87 138.43 58.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.441 . . . . 0.0 110.798 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 37' ' ' VAL . 31.4 pt -83.32 1.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 ' H ' ' HG2' ' A' ' 53' ' ' GLU . 1.6 tm? -105.24 104.07 13.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 -179.73 27.09 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.9 m -128.11 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.756 0.278 . . . . 0.0 110.949 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 33' ' ' GLU . 57.3 m-85 -54.41 116.63 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.785 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' ASN . 1.2 p -141.6 173.68 11.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -75.05 -23.61 58.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.007 0.432 . . . . 0.0 110.507 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 15.3 m -81.44 120.79 79.06 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.682 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 38.5 Cg_exo -60.31 108.92 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.089 0 C-N-CA 122.75 2.3 . . . . 0.0 112.442 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -93.16 106.59 18.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 109.998 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -96.26 116.58 29.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 54' ' ' ILE . 58.6 mt -97.6 111.35 27.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.921 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.96 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 90.4 m-20 -82.07 100.84 9.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 50' ' ' TYR . 46.4 mm -97.39 106.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.78 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.97 117.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.908 0.385 . . . . 0.0 111.735 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -104.54 135.85 45.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 176.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -124.18 125.25 44.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.787 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -64.06 126.81 28.89 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 44' ' ' GLY . 20.2 pttp -87.69 134.42 33.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.176 0.512 . . . . 0.0 111.259 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . -82.77 -50.79 0.73 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.451 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 73' ' ' ALA . 39.4 Cg_endo -66.7 163.44 33.07 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.778 1.652 . . . . 0.0 111.844 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.89 -70.75 0.19 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.162 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.83 28.02 13.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.257 0.551 . . . . 0.0 110.289 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.95 32.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.709 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.66 10.75 10.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.947 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.08 95.38 0.72 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.265 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -75.83 132.29 40.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 170.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -71.14 77.3 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.206 0.527 . . . . 0.0 112.116 -169.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -140.66 -51.51 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -120.09 174.08 6.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.309 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 55.89 48.35 18.19 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.6 0.563 . . . . 0.0 109.987 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.443 -173.247 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.668 0.271 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -60.46 2.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.296 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -92.57 25.57 3.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.895 0.378 . . . . 0.0 111.329 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.11 -37.96 87.7 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt 66.91 95.53 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.192 0 C-N-CA 123.596 0.758 . . . . 0.0 110.883 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.2 177.49 7.75 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.112 2.541 . . . . 0.0 113.261 -172.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 61.06 76.09 0.38 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.919 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -124.52 97.74 5.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 66.6 t -87.38 131.46 35.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.372 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -89.13 109.14 20.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.5 t -97.4 111.43 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.147 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -102.18 117.34 34.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.282 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 91.1 m-85 -88.95 98.03 11.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.835 0.35 . . . . 0.0 110.285 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 68' ' ' ILE . 77.7 mt -95.9 134.43 38.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.295 0.569 . . . . 0.0 110.762 -177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -61.58 -55.8 26.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.832 -175.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 2.9 tm-20 169.52 -36.08 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -87.59 21.14 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.114 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 66.58 15.15 10.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.556 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -88.89 125.89 35.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.193 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 t -77.03 108.22 9.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 pt -96.31 -10.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -128.14 137.5 30.97 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.24 118.36 4.25 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.957 2.438 . . . . 0.0 112.374 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 m -51.87 122.5 8.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.67 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.94 154.94 20.33 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.246 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 74.9 m-85 -99.75 104.78 16.51 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.261 0.553 . . . . 0.0 110.969 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 55.7 tp -72.54 114.15 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.591 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -120.96 156.24 32.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.64 -158.95 20.67 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.939 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 77.9 mt -99.42 160.22 14.44 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -65.11 135.66 55.78 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.02 15.69 6.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.66 124.52 34.66 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.16 19.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.343 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 46.6 p90 -104.31 169.33 8.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.28 0.562 . . . . 0.0 111.81 -174.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -131.52 131.18 43.21 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 54' ' ' ILE . 31.9 m -78.06 123.49 86.12 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.192 0.52 . . . . 0.0 111.462 -173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.64 125.12 11.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.267 . . . . 0.0 111.933 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.5 150.16 30.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.676 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -126.83 141.96 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.241 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -97.26 91.9 5.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.496 HG22 ' HG3' ' A' ' 43' ' ' LYS . 60.9 mt -103.17 122.62 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.975 -174.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HG3' HG22 ' A' ' 42' ' ' ILE . 64.6 mttm 59.56 29.72 19.3 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.556 0.535 . . . . 0.0 112.416 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.98 44.4 61.6 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -96.13 163.84 12.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.111 0.482 . . . . 0.0 110.599 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.9 m -139.8 138.62 35.99 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' TYR . 45.1 tp -50.8 125.82 14.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 65.6 tp -72.1 -58.57 3.32 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 60.2 tttm 167.94 138.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.752 -176.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HE1' ' HA ' ' A' ' 53' ' ' GLU . 2.6 p90 -91.3 171.21 9.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -47.3 -53.79 12.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -141.71 -81.66 0.22 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.726 0.298 . . . . 0.0 110.721 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 37.9 mt-10 -142.33 165.02 28.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.952 175.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 37' ' ' VAL . 16.4 pt -107.22 18.71 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.441 0.639 . . . . 0.0 110.225 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.79 82.46 8.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.381 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.55 28.89 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.143 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.7 157.9 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 67.3 m-85 -64.29 131.69 48.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.987 0.423 . . . . 0.0 111.032 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 p -131.55 175.61 9.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.92 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -77.61 -6.25 53.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.072 0.463 . . . . 0.0 110.78 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 m -89.9 129.53 46.0 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.3 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.5 105.01 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.504 2.136 . . . . 0.0 111.304 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' VAL . 98.5 mt-30 -85.87 145.36 27.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.2 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -118.78 107.61 13.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.23 0.538 . . . . 0.0 110.166 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.0 mt -106.5 102.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.005 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -86.15 96.14 9.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.891 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 mm -80.22 95.47 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.556 HG12 HD12 ' A' ' 14' ' ' LEU . 67.2 mt -95.54 113.46 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.559 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' LEU . 55.4 m-85 -86.12 -176.75 6.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.321 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 57.2 tt0 -143.82 127.07 16.65 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.428 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 73' ' ' ALA . 88.8 tttt -62.66 125.38 23.76 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -69.6 -2.57 11.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.746 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' H ' ' HG2' ' A' ' 71' ' ' LYS . . . 50.04 79.5 0.34 Allowed Pre-proline 0 N--CA 1.463 0.192 0 O-C-N 123.748 0.655 . . . . 0.0 111.212 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.89 94.41 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.729 2.286 . . . . 0.0 112.367 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.24 139.63 46.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.52 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.03 -10.82 59.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.373 0.606 . . . . 0.0 110.322 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.42 -23.46 63.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.203 173.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.78 158.97 17.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.764 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -119.56 -179.32 3.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.642 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 63.65 35.21 11.71 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.937 170.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -74.08 -33.52 63.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -115.99 111.1 19.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.244 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -64.79 -37.26 87.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.09 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -107.0 95.08 5.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.561 178.157 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.56 120.72 26.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 167.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -78.95 56.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.02 167.25 50.98 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 174.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.27 121.86 48.71 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.955 0.378 . . . . 0.0 110.919 -178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.35 100.48 1.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.42 2.08 . . . . 0.0 111.224 173.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -73.05 108.85 6.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.44 136.49 54.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.304 0.574 . . . . 0.0 110.983 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.8 t -98.46 130.96 46.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.302 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -92.14 104.51 16.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 50.5 t -96.21 130.05 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.873 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -126.16 131.1 52.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.406 . . . . 0.0 110.019 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 37.1 m-85 -94.91 108.97 21.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 18' ' ' ASN . 81.4 mt -105.16 141.86 35.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.049 0.452 . . . . 0.0 111.355 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -102.58 89.43 3.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.636 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 64.27 -74.99 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.974 0.91 . . . . 0.0 112.749 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.6 p-10 -83.31 21.11 1.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.317 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 14' ' ' LEU . 88.0 m-20 74.21 21.57 2.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.575 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -67.52 115.55 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.898 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 m -74.28 92.88 2.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.208 0.527 . . . . 0.0 109.766 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 tt -86.36 -26.88 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.044 -175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -114.7 150.5 44.1 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.229 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 22' ' ' ALA . 24.7 Cg_exo -63.1 139.47 73.09 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.656 2.237 . . . . 0.0 111.86 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p -51.39 119.65 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.585 0.553 . . . . 0.0 111.294 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.3 tp -89.12 109.97 20.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.409 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -86.41 98.13 10.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.193 0.52 . . . . 0.0 109.791 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.5 tp -86.76 111.72 20.99 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.908 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.6 t -108.2 149.64 28.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.925 0.393 . . . . 0.0 111.035 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.23 -172.27 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.91 165.16 19.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.956 0.378 . . . . 0.0 110.434 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -68.41 135.54 51.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.6 t30 70.56 10.99 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.684 0.615 . . . . 0.0 110.849 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 58' ' ' PHE . 33.7 tt0 -81.2 125.17 29.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.39 109.74 11.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 17.2 p90 -91.36 159.14 16.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.235 0.541 . . . . 0.0 111.8 -174.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -104.96 128.59 53.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.36 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 54' ' ' ILE . 61.4 t -88.71 116.44 66.29 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.762 0.315 . . . . 0.0 110.813 -176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 6.0 Cg_exo -78.59 102.09 1.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.943 2.429 . . . . 0.0 111.89 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 59.7 mtt -91.06 108.39 19.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -89.87 135.29 33.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.462 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 60.3 tttp -88.88 91.53 8.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.2 mt -79.38 117.54 25.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.796 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 55.67 26.53 9.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 111.423 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 41' ' ' LYS . . . 78.03 10.15 86.43 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.52 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -58.12 159.04 6.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.536 0.668 . . . . 0.0 111.872 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -107.14 145.17 32.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.28 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -71.0 113.22 7.82 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.076 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 58.0 tp -60.76 -57.85 10.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.567 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -173.03 124.92 0.43 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.827 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CE2' HG23 ' A' ' 54' ' ' ILE . 5.3 t80 -87.98 94.7 9.87 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.209 0.528 . . . . 0.0 110.158 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.46 -12.85 38.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.336 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -88.01 -172.43 3.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.977 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.79 154.13 31.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.943 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 50' ' ' TYR . 5.3 pt -132.37 170.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.6 mt 63.6 23.77 13.7 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.833 0.708 . . . . 0.0 111.247 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.26 165.46 41.2 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.094 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.67 144.9 15.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.625 0.25 . . . . 0.0 110.345 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 75.1 m-85 -58.88 110.09 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.142 0.496 . . . . 0.0 111.151 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -103.99 165.12 11.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.059 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -9.55 54.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.471 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -94.62 118.97 66.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.11 113.44 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.745 2.297 . . . . 0.0 111.88 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -90.58 150.48 21.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -121.07 120.14 34.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.901 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 11' ' ' VAL . 69.4 mt -107.41 99.97 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.34 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -91.36 112.77 24.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.979 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -104.61 112.99 40.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.568 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.1 mt -99.84 115.84 41.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.289 0.566 . . . . 0.0 111.711 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -99.82 169.56 9.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.831 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 44.5 tt0 -129.77 132.28 46.5 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -68.36 135.14 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.474 ' NZ ' ' HB2' ' A' ' 72' ' ' LYS . 9.3 mtmp? -69.76 143.01 53.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.926 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -68.93 166.62 26.08 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.681 172.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 86.5 Cg_exo -45.04 106.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.802 2.335 . . . . 0.0 112.82 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.39 -19.69 62.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.195 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -79.02 -15.8 57.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.36 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.26 -15.15 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.648 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.7 114.46 25.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.815 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.64 139.44 58.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.001 0.429 . . . . 0.0 110.501 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -75.4 -34.06 61.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.576 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -86.27 113.71 22.5 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 166.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -58.21 -24.5 59.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.1 t60 68.48 11.59 8.41 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.273 0.358 . . . . 0.0 111.373 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -114.83 134.76 54.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.165 0.507 . . . . 0.0 110.948 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.16 -0.924 . . . . 0.0 109.057 174.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.95 0.405 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -165.96 160.53 16.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.376 -175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.3 101.1 5.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 158.57 178.44 32.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.604 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 9.8 mtmp? -127.04 168.13 15.62 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 5' ' ' LYS . 86.0 Cg_exo -48.2 111.78 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.675 2.25 . . . . 0.0 112.77 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' A' ' 28' ' ' SER . 42.6 t-20 -77.76 114.33 16.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.33 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.9 mt-30 -114.37 120.26 39.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.161 0.505 . . . . 0.0 112.059 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 71.2 t -95.26 102.25 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -92.62 106.89 18.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.28 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.13 106.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.186 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -95.04 136.7 35.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.097 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 96.2 m-85 -105.93 104.05 13.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.84 0.353 . . . . 0.0 110.574 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.65 159.1 16.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' TYR . 10.0 t70 -86.59 -64.35 1.16 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.665 0.745 . . . . 0.0 109.246 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.727 ' HG3' HE21 ' A' ' 70' ' ' GLN . 1.4 tt0 -174.82 -30.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.183 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -70.76 6.91 1.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.352 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.9 t30 67.73 14.42 9.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.358 0.599 . . . . 0.0 110.715 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -97.38 128.03 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.806 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 108.99 4.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.977 0.418 . . . . 0.0 110.358 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -85.84 -13.56 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.5 154.38 78.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.886 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.68 140.24 92.87 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.046 2.498 . . . . 0.0 112.69 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.3 m -61.71 124.55 21.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.29 106.21 18.3 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 27.1 p90 -116.29 125.12 51.73 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.328 0.585 . . . . 0.0 111.545 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' GLN . 78.6 mt -93.22 159.38 15.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.904 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' ASN . 49.0 m -135.57 119.42 17.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.091 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 -170.7 12.59 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.953 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 58' ' ' PHE . 88.3 mt -95.22 168.45 10.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.82 0.343 . . . . 0.0 111.092 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 60' ' ' GLU . 33.6 t80 -65.09 132.86 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.188 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.19 17.82 10.34 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.938 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -89.2 141.1 28.81 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.35 131.2 37.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.076 0.465 . . . . 0.0 111.723 -174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 30.2 p90 -128.18 155.71 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.156 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -128.26 155.83 43.96 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.05 114.36 61.5 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.642 0.258 . . . . 0.0 110.539 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.76 107.37 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 44.3 ttm -81.93 110.14 16.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.386 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -96.35 137.05 36.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -101.5 105.55 16.55 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 mt -71.78 151.94 8.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.29 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.81 98.54 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.8 0.687 . . . . 0.0 111.703 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.58 48.67 7.8 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.541 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.98 158.53 44.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 48' ' ' LEU . 87.7 m -141.06 136.95 32.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 47.4 tp -56.73 -35.8 68.97 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.7 tp 72.07 -66.67 0.29 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.652 0.381 . . . . 0.0 111.342 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -152.2 161.72 42.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.705 0.288 . . . . 0.0 110.756 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' HE1' HD12 ' A' ' 67' ' ' ILE . 0.8 OUTLIER -108.16 100.19 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.975 0.417 . . . . 0.0 109.994 169.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.91 -15.09 58.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.497 0.665 . . . . 0.0 109.94 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -131.54 140.53 49.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.65 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 129.38 34.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.3 pt -105.87 168.82 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.023 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.3 tp 65.15 106.61 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.98 0.8 . . . . 0.0 111.537 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.14 -140.63 3.55 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.279 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.78 147.94 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.799 0.299 . . . . 0.0 110.827 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m-85 -61.13 107.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -77.76 155.75 30.99 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 31' ' ' PHE . 34.4 mt-10 -60.31 -27.24 67.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.779 0.324 . . . . 0.0 111.715 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.8 p -85.71 120.48 72.9 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.585 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.52 123.33 11.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.946 2.431 . . . . 0.0 111.968 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -91.04 124.1 35.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 -173.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.1 m -102.55 96.1 6.68 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.91 113.62 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.859 -174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -91.26 106.31 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.478 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.503 HD12 ' HE1' ' A' ' 50' ' ' TYR . 50.1 mm -96.62 140.54 17.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 47' ' ' LEU . 76.0 mt -119.14 132.2 69.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.616 0.246 . . . . 0.0 111.015 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 47.6 m-85 -133.16 115.32 14.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.727 HE21 ' HG3' ' A' ' 16' ' ' GLU . 86.9 mt-30 -93.77 153.43 18.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.564 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -63.29 114.09 3.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.101 0.477 . . . . 0.0 109.93 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 26.4 ttpt -70.68 -27.09 63.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.923 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.26 94.89 37.57 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.42 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -92.3 145.73 2.81 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.949 2.433 . . . . 0.0 111.655 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.65 163.56 21.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.106 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -81.83 -10.32 59.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.21 0.529 . . . . 0.0 109.853 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.29 14.18 4.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.946 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.6 tp -160.94 168.36 24.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -131.9 155.96 46.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.902 0.382 . . . . 0.0 110.611 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -79.88 -21.39 44.09 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.97 -39.67 75.04 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.446 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -134.41 110.82 9.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.783 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.524 ' HB2' ' H ' ' A' ' 85' ' ' HIS . 2.0 m80 -79.83 -168.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -73.61 -8.4 55.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.496 0.665 . . . . 0.0 109.225 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.524 ' H ' ' HB2' ' A' ' 83' ' ' HIS . 92.0 m-70 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.947 -1.025 . . . . 0.0 108.329 171.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.196 0.522 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.77 159.96 21.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.093 174.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -86.09 -12.38 50.22 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.38 -154.11 19.74 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.762 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 37.4 mtmm -122.09 134.98 24.98 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 7.3 Cg_exo -73.04 78.19 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.76 2.307 . . . . 0.0 112.043 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -79.4 70.01 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.65 149.21 24.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.759 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 19.6 t -97.68 116.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.219 176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -89.14 105.93 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.862 0.363 . . . . 0.0 110.146 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 58.8 t -87.79 107.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.922 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 12' ' ' ASN . 7.9 m120 -103.98 115.6 30.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.706 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 72.2 m-85 -88.65 102.84 15.36 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.4 mt -111.68 165.21 12.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.184 0.516 . . . . 0.0 112.18 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 19.8 p-10 -90.2 -52.44 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.9 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 15' ' ' ASP . 44.1 tt0 167.29 -37.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.508 1.123 . . . . 0.0 108.205 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.13 19.87 5.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.584 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 66.69 38.45 3.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.972 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -97.05 116.64 29.61 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.452 173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.6 m -67.91 99.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.51 -21.34 15.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.334 0.588 . . . . 0.0 109.988 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -135.52 151.52 74.74 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.161 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.96 150.03 66.7 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.76 2.307 . . . . 0.0 112.505 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.1 p -66.61 115.21 6.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 67.6 tp -88.94 114.68 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.022 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -91.36 95.86 10.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.339 0.59 . . . . 0.0 110.554 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 65.5 tp -83.71 96.56 8.75 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.839 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.5 t -118.8 145.49 45.58 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.21 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.4 -136.08 2.19 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.727 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -97.49 158.41 15.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.722 0.296 . . . . 0.0 110.281 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -70.38 136.27 49.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.9 t30 66.19 19.59 11.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.383 0.611 . . . . 0.0 110.666 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -92.68 138.59 31.37 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.28 36.97 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -125.92 155.48 41.22 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -112.56 141.68 46.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 62.1 t -100.79 115.32 65.47 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.662 0.268 . . . . 0.0 110.818 -174.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 37' ' ' VAL . 5.4 Cg_exo -74.32 108.21 2.62 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.064 2.509 . . . . 0.0 111.955 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.7 ttm -91.24 135.68 33.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.087 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -109.53 148.43 31.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.346 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.58 101.23 10.7 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.6 101.83 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.433 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 56.61 35.22 25.76 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' HE3' ' A' ' 72' ' ' LYS . . . 81.07 46.94 6.79 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.668 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.89 163.95 13.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.771 0.319 . . . . 0.0 110.443 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.1 m -115.53 138.02 51.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.727 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.3 tp -68.9 123.96 22.42 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.144 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 68.4 tp -85.17 -48.22 9.36 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.011 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttp 178.08 137.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.48 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -95.88 113.83 25.49 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 167.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 23.9 t0 -81.31 43.72 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.636 0.732 . . . . 0.0 111.169 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' A' ' 65' ' ' ILE . 36.1 m -160.37 173.78 15.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -106.95 127.32 53.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD13 ' A' ' 65' ' ' ILE . 35.6 pt -101.14 175.28 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.425 -172.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 tp 65.52 27.05 11.71 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.848 0.717 . . . . 0.0 111.069 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.63 -152.03 28.52 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.864 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.99 155.56 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.8 110.12 1.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.592 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.5 p -81.19 -178.76 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.763 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.65 12.58 2.49 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.665 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.8 m -147.48 143.48 18.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 31.3 Cg_exo -59.28 120.04 7.64 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.788 2.325 . . . . 0.0 111.77 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB2' HG13 ' A' ' 9' ' ' VAL . 73.5 mt-30 -87.92 155.72 19.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.251 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -130.96 100.14 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.854 0.359 . . . . 0.0 110.043 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 54' ' ' ILE . 53.2 mt -91.73 105.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.076 0.465 . . . . 0.0 110.124 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 53.1 m-80 -85.12 97.79 10.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.246 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 mt -92.97 104.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.6 mt -97.94 127.05 50.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.203 -172.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -110.12 124.91 52.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.706 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 38.6 tt0 -90.83 136.38 33.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.862 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -75.73 110.67 10.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.77 0.319 . . . . 0.0 110.215 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 19.0 pttp -72.17 142.5 49.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 63.34 96.09 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 123.659 0.599 . . . . 0.0 110.926 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.92 155.54 67.35 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.988 2.458 . . . . 0.0 112.847 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.92 147.46 50.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.298 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.55 -54.77 5.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.558 ' HB1' ' HE1' ' A' ' 80' ' ' HIS . . . -85.33 132.28 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 30.5 tp -78.9 172.15 14.19 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' N ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -64.44 115.3 4.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.933 0.397 . . . . 0.0 110.587 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.558 ' HE1' ' HB1' ' A' ' 77' ' ' ALA . 29.2 m80 -102.84 109.64 21.28 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -65.54 -30.57 71.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.163 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -90.97 22.06 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.112 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -136.3 -53.27 0.73 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -95.73 91.35 6.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.838 -178.127 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.664 0.268 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -100.04 72.24 1.67 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.911 0.386 . . . . 0.0 110.079 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -161.88 6.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.369 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.21 6.94 25.08 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.19 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -118.4 100.93 51.43 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-O 120.826 0.345 . . . . 0.0 110.117 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.28 106.33 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.997 2.465 . . . . 0.0 111.822 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 60' ' ' GLU . 90.1 m-20 -78.49 127.61 32.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.428 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HG2' ' HA ' ' A' ' 28' ' ' SER . 97.2 mt-30 -106.37 132.78 52.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 111.282 -177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 76.9 t -86.97 128.11 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -89.41 113.2 24.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.088 0.47 . . . . 0.0 110.199 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 25' ' ' LEU . 43.9 t -87.79 109.29 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.117 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -98.39 112.92 24.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.032 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 87.5 m-85 -86.63 103.87 15.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.503 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.3 mt -101.88 -175.22 2.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.462 0.649 . . . . 0.0 111.968 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.4 t70 -124.46 172.47 9.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.399 -173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.11 -40.07 92.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.235 0.541 . . . . 0.0 109.801 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.77 4.12 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.762 0.791 . . . . 0.0 109.086 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 61.74 83.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.4 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 39.1 m -155.98 143.9 19.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -67.52 106.21 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.904 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 ' HB2' ' A' ' 15' ' ' ASP . 20.5 pt -90.86 -25.55 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.86 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' TYR . . . -125.65 147.44 58.37 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.916 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.93 139.22 84.17 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.79 2.326 . . . . 0.0 112.178 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -59.39 129.08 40.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.937 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 49.6 tp -90.23 141.44 28.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.874 0.368 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.66 110.95 22.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.869 -175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' TYR . 53.4 tp -97.51 94.08 6.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.667 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 21.4 m -77.12 130.59 37.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.569 -175.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CZ ' ' A' ' 58' ' ' PHE . . . -147.29 -170.75 15.78 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 31' ' ' PHE . 17.6 tp -124.94 173.13 8.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.997 0.398 . . . . 0.0 110.247 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 60' ' ' GLU . 45.6 t80 -58.0 128.16 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.831 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.36 68.48 0.83 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.708 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -148.04 142.61 26.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.86 165.97 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.34 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 54.3 p90 -146.7 158.64 43.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 112.193 -174.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -116.88 130.3 56.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.0 172.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.23 118.92 67.84 Favored Pre-proline 0 C--N 1.322 -0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.678 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.25 106.82 2.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.021 2.481 . . . . 0.0 112.603 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.8 mtt -79.36 153.46 29.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.31 145.14 48.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.972 0.415 . . . . 0.0 110.983 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 6.4 ttpm? -93.65 94.33 8.54 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 166.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 45' ' ' TYR . 47.4 mt -71.44 150.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.83 100.5 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 112.303 -171.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 20.82 61.3 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.472 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 43.0 m-85 -116.28 162.33 17.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.139 0.495 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 72' ' ' LYS . 20.5 m -148.77 133.28 17.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.0 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.89 116.27 3.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.512 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . 52.3 tp -72.57 -44.48 62.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -174.83 146.64 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.847 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -90.74 91.42 8.37 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.802 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.92 66.98 8.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.886 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 t -179.05 170.44 1.45 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.56 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -126.98 123.09 36.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.956 0.408 . . . . 0.0 109.935 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.54 33.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.692 -172.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.0 173.0 6.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.724 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.12 -168.27 14.16 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.548 -0.835 . . . . 0.0 111.877 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.44 155.19 41.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.443 0.163 . . . . 0.0 110.861 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 35' ' ' TYR . 94.4 m-85 -55.66 -33.26 63.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.217 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 m 54.66 -130.25 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.494 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 31' ' ' PHE . 5.1 mm-40 -126.87 21.23 6.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.393 0.616 . . . . 0.0 109.727 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -124.69 123.71 25.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.549 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.29 105.25 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.168 1.912 . . . . 0.0 110.747 172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -88.21 162.37 16.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.426 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.0 m -130.77 122.49 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.848 0.356 . . . . 0.0 110.401 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.7 mm -101.4 115.09 42.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.45 108.47 19.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.33 110.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 15' ' ' ASP . 71.2 mt -94.86 115.97 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.193 0.52 . . . . 0.0 112.025 -172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 13' ' ' TYR . 94.4 m-85 -105.42 149.4 26.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.973 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 52.5 tt0 -115.65 125.86 53.42 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.773 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -70.56 133.78 47.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 46' ' ' THR . 49.7 mtmt -76.53 74.6 3.25 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.878 0.37 . . . . 0.0 110.611 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 135.22 96.27 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.173 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.71 116.83 2.82 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.841 2.36 . . . . 0.0 112.181 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.74 -38.74 73.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.977 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -75.37 102.41 5.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.73 -172.77 2.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.1 8.77 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 0.0 110.8 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -144.05 164.45 30.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -72.99 -15.59 61.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.044 0.449 . . . . 0.0 110.942 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -136.94 167.84 20.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.725 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -101.53 136.31 41.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -74.77 83.54 2.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.1 t60 171.21 -37.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 114.552 -1.203 . . . . 0.0 109.648 175.564 . . . . . . . . 0 0 . 1 stop_ save_